Next Article in Journal
HRMS Characterization, Antioxidant and Cytotoxic Activities of Polyphenols in Malus domestica Cultivars from Costa Rica
Next Article in Special Issue
Triptycene Derivatives: From Their Synthesis to Their Unique Properties
Previous Article in Journal
Hydrothermal Synthesis of Silicoaluminophosphate with AEL Structure Using a Residue of Fluorescent Lamps as Starting Material
Previous Article in Special Issue
Radical and Ionic Mechanisms in Rearrangements of o-Tolyl Aryl Ethers and Amines Initiated by the Grubbs–Stoltz Reagent, Et3SiH/KOtBu
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Efficient Approach to 2-CF3-Indoles Based on ortho-Nitrobenzaldehydes

by
Vasiliy M. Muzalevskiy
1,
Zoia A. Sizova
1,
Vladimir T. Abaev
2,3 and
Valentine G. Nenajdenko
1,*
1
Department of Chemistry, Lomonosov Moscow State University, 119899 Moscow, Russia
2
North Ossetian State University, 44-46 Vatutina St., 362025 Vladikavkaz, Russia
3
North Caucasus Federal University, 1a Pushkin St., 355009 Stavropol, Russia
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(23), 7365; https://doi.org/10.3390/molecules26237365
Submission received: 13 November 2021 / Revised: 28 November 2021 / Accepted: 2 December 2021 / Published: 4 December 2021

Abstract

:
The catalytic olefination reaction of 2-nitrobenzaldehydes with CF3CCl3 afforded stereoselectively trifluoromethylated ortho-nitrostyrenes in up to 88% yield. The reaction of these alkenes with pyrrolidine permits preparation of α-CF3-β-(2-nitroaryl) enamines. Subsequent one pot reduction of nitro-group by Fe-AcOH-H2O system initiated intramolecular cyclization to afford 2-CF3-indoles. Target products can be prepared in up to 85% yields. Broad synthetic scope of the reaction was shown as well as some followed up transformations of 2- CF3-indole.

1. Introduction

Indole has been discovered in 1866 by Bayer [1]. This type of heterocycles became an object of intensive investigations [2,3,4,5,6,7,8] and recognized as a “privileged structure” in drug discovery [9]. Indole motif is an important structural unit of many pharmaceuticals and natural products [10]. Seven derivatives of indole can be found in the list of 200 best selling drugs in 2020. Tagrisso ($4.328 Bn), Trikafta ($3.864 Bn), Ofev ($2.448 Bn), Leuprorelin ($1.834 Bn), Alecensa ($1.292 Bn), Zoladex ($ 0.888 Bn) and Sutent ($0.819 Bn) were sold for more than $ 15 billion totally in 2020 worldwide [11].
Chemistry of fluorinated organic compounds is a booming area of modern organic chemistry, which is a result of unique physicochemical as well as biological properties of these compounds [12,13,14,15,16,17,18,19,20,21,22,23]. Thus, about 20% (more than 300 compounds) of currently used drugs [24,25,26,27,28,29,30,31] contain at least one fluorine atom [32]. In 2020, approximately 25% (14 out of 53) of all drugs and about 35% (14 out of 40) of “small-molecule drugs” approved by the FDA are fluorinated compounds [33]. At the same time, about 59% of all small-molecule drugs have a nitrogen heterocyclic motif [10]. Last year revealed, that three out of every four small-molecule drugs approved by the FDA in 2020 (28 out of 37) are representatives of that class [33]. Hence, elaboration of novel pathways to fluorinated nitrogen heterocycles are of great demand [34,35,36,37,38,39,40,41].
The brilliant example of such interest are 2-CF3-indoles. According to the Reaxys database, this class of compounds enjoyed a boom of attention last decade. Thus, 107 out of 152 research articles dealing with 2-CF3-indoles were published from 2011 to 2021. Previous decade revealed 19 articles, and 26 articles were published in period from 1977 to 2001 [42]. These massive investigations gained several promising bioactive 2-CF3-indoles (Figure 1). The 2′-trifluoromethyl analogue of Indomethacin I was appeared to be a potent and selective COX-2 inhibitor [43]. Compound II having 2-CF3-indole and cinnamic amide moieties possess anti-inflammatory and neuroprotective actions [44]. Indolyl-pyridinyl-propenone III was found to possess properties of antiproliferative [45] and antineoplastic agent [46]. 2-CF3-indole IV revealed antifungal properties (Figure 1) [47].
Most synthetic approaches to such indoles can be divided to the methods of direct trifluoromethylation of indole core and cyclizations of various precursors having CF3 group in appropriate position [38]. Both radical and electrophilic trifluoromethylations was performed using bis(perfluoroalkanoyl) peroxides [48], difluorodiiodomethane [49], hypervalent iodine reagents [50,51,52,53], CF3I [54,55,56,57,58], Umemoto’s reagents [59,60], [(phen)CuCF3] [61], and CF3SO2Na [62,63,64,65]. Cyclization approaches are based on formation of C2-C3 bond as a key step and deal with transformations of compounds having ortho-toluidine fragment [66,67,68,69,70,71,72,73,74,75,76]. One work reported transformation of 4- and 6-nitro-1-hydroxy indoles to NH indoles under treatment with bromoacetophenone (Figure 2) [77].
Several years ago, we have elaborated convenient approach to α-CF3-β-aryl enamines on the base of the reaction of β-chloro-β-trifluromethylstyrenes with amines [78,79,80]. This potent CF3-building blocks were successfully used as synthetic equivalents of trifluoromethyl benzyl ketones in the Fisher and Pictet–Spengler reaction to give 2-CF3-3-arylindoles and CF3-β-carbolines [81], synthesis of CF3-enones [82,83,84] and α-CF3-phenethylamines [85]. In continuation of the investigation of synthetic potential of α-CF3-β-aryl enamines, we report in this article one pot two step synthesis of 2-CF3-indoles (Figure 2).

2. Results

First, we investigated olefination of 2-nitrobenzaldehydes 1 to prepare the corresponding trifluoromethylated styrenes 2. The catalytic olefination reaction (COR) [15,86,87,88,89,90] and Wittig reaction were used for the synthesis of these alkenes. We performed screening of the reaction conditions for COR (see Supplementary Materials, Scheme S1). It was found, that ethylene glycol [89] is the solvent of choice for these substrates, in contrast to EtOH traditionally used for COR with CF3CCl3 [90]. It was also found, that the yield is very sensitive to the nature of the substituents (additional to ortho-nitro group) in aryl ring. The best yield in the whole series was obtained for unsubstituted 2-nitrobenzaldehyde, which was transformed by COR to styrene 2a in 88% yield. In the case of additional alkyl-, alkoxy- and halogen substituents in the aryl ring corresponding styrenes were isolated in good to high yields. However, in the case of aldehydes 1j,l,m having strong EWG substituents (nitro-, cyano- and carboxymethyl- groups) in 4-position the corresponding alkenes 2j,l,m were synthesized in lower yields using COR. Therefore, we tried also alternative synthesis based on Wittig olefination. As a result, some improvement was observed for these problematic aldehydes. It should be noted that olefination of 2-nitrobenzaldehydes using both methods proceeds stereoselectively to form mostly Z-isomer in up to 96:4 ratio with minor E-isomer. Assignment of the configuration of the isomers was maintained by comparison with the literature NMR data of similar styrenes without ortho-nitro-group [90] (Scheme 1).
Having in hand a series of trifluoromethylated ortho-nitrostyrenes, we investigated their transformation to 2-CF3-indoles. The treatment of styrenes 2 with an access of pyrrolidine at room temperature led to α-CF3-enamines 3 in high yield. We assumed, that reduction of ortho-nitro aryl derived α-CF3-enamines 3 could led to 2-CF3-indoles 4 through formation of intermediate anilines 3′ [91,92]. The reduction of model enamine 3a was studied in various conditions. It was found, that HCO2H-Pd/C, Fe-AcOH-H2O and Zn-AcOH-H2O systems worked well to give 2-CF3-indole 3a in 85, 86 and 85% yield correspondingly according to 19F NMR. Although all these systems showed almost equal results, we used Fe-AcOH-H2O for our further transformations due to the lower price and toxicity of iron [93]. It should be noted, that crude enamine 3a can be used directly after evaporation of excessive pyrrolidine. So, the transformation of styrene 2 into indole 4 can be maintained as a one pot reaction without isolation of intermediate enamine 3. Moreover, this one pot conditions work for multigram scale reaction to afford 3.257 g (72%) of indole 4a in one run (Scheme 2).
Using these optimal conditions, we performed the synthesis of various 2-CF3-indoles 4. It was found that the reaction has a general character allowing to prepare 2-CF3-indoles having both electron-donating and electron-withdrawing groups in various positions of indole ring in good to high yield. 6-Amino-2-CF3-indole 4j was synthesized in the case of styrene 2j having additional nitro-group. This indole is a perspective object for further modifications at amino group, which can provide compounds interesting for the medicinal chemistry.
One can notice that indoles 4 were mostly prepared in the yields higher than 50%, which is high enough taking into account the three step transformation. In contrast, indoles 4e and 4i were obtained in moderate yield (43% and 25%). The explanation of that fact is a side process taking place at the step of formation of enamine 3. Thus, monitoring of the reaction mixture in the reaction of 2c with pyrrolidine revealed the presence of compound 5c, which was isolated in 15% yield together with enamine 3c (80%). The structure of 5c was assigned by means of NMR and HRMS data. Thus, the key signals of 5c are the signals of carbonyl group (192.4 ppm), quaternary aminal carbon adjacent to CF3-group (quadruplet at 86.4 ppm, JCF = 28.1 Hz) in 13C NMR and N-OH group (7.74 ppm) in 1H NMR. We have also observed formation of similar N-hydroxy indolin-3-ones 5 in several other reactions. Thus, in case of enamines 3e and 3i the admixture of compounds 5e and 5i were 28% and 39%, correspondingly (by 19F NMR; see Supplementary Materials for details). Even in the case of enamine 3a we observed formation of 5a in 4% yield (by 19F NMR). We did not investigate this side reaction thoroughly, but possible mechanism of this transformation was proposed using the literature data (Scheme 3) [94,95]. At first step dehydrochlorination of 2c leads to alkyne 6 [78]. Next, it is attacked by pyrrolidine to give zwitterion 7. Proton transfer in 7 affords enamine 3c. Alternatively, transformation of 7 leads to transfer of oxygen to form nitroso compound 8. This intermediate has in the structure a strong electron-donating fragment of “enoloenamine”. Intramolecular attack of this fragment to nitroso group led to indolin-1-olate derivative 9. Its protonation leads to N-hydroxy indolin-3-one 5c.
Interesting results were obtained in the case of styrenes 2n,o. These alkenes have halogens in para-position to nitro-group, which activates nucleophilic substitution of them. It was found that treatment of 4-fluorostyrene 2o with pyrrolidine led to substitution of both fluorine and chlorine during 1–2 h to give enamine 3n in 90% yield (Scheme 4). Similarly, substitution of both chlorine atoms in 4-chlorostyrene 2n afforded enamine 3n in 72% yield. However, in this case about 2–3 days were needed for full substitution of chlorine adjacent to aryl ring. It is not surprising, because fluorine is a better leaving group than chlorine. Next, we performed one pot synthesis of indole 10a from 4-fluorostyrene 2o. As a result, indole 10a was isolated in 45% yield (Scheme 4).
We proposed that using less nucleophilic amines would allow to perform selective synthesis of enamine without substitution of halogen in aryl ring. However, the reaction of 4-fluorostyrene 2o with piperidine afforded a mixture of enamine 11a and styrene 2p at room temperature. The heating of this reaction mixture at 90 °C for 3 h led to selective transformation of 2p into 11a (by 19F NMR), which was converted into indole 10b in 44% yield (one-pot). To our delight, the reaction of 4-chlorostyrene 2n with piperidine proceeded only at the double bond to form enamine 11b (observed in 19F NMR) after 1h at room temperature. One pot transformation of 11b under standard conditions afforded 5-chloro-2-CF3-indole 4n in total 71% yield (Scheme 5).
To investigate the scope of the synthesis of 5-amino substituted indoles, we performed several reactions of styrene 2o with other primary and secondary amines. As a result, new family of 2-CF3-indoles 10c–g having amine fragments of morpholine, azepane, diethylamine, methylamine and n-hexylamine was synthesized in good yields (Scheme 6).
Having prepared a set of 2-CF3-indoles we found surprisingly that many typical reactions known for indoles are unknown for 2-CF3-indoles. To fill this gap, we maintained reactions of indole 4a with several C-centered electrophiles. In our hands, formylation reaction by POCl3-DMF afforded 3-formyl-2-CF3-indole 17 in 53% yield. Friedel–Crafts acylation with AcCl-AlCl3 led to corresponding ketone 18 in 64% yield. Reaction with ethoxy CF3-enone 19 under catalysis with BF3·Et2O gave α,β-unsaturated CF3 ketone 20, which is a valuable building block for the synthesis of complex fluorinated molecules. Very interesting results were observed in the reactions of 2-CF3-indole with arylaldehydes in the media of alcohols under catalysis with MeSO3H. The reaction with benzaldehyde, 4-chloro- and 4-methoxybenzaldehydes in methanol afforded methoxy-derivatives 21 in good yields. The reaction with 1.2 equivalents of benzaldehyde in ethanol led to ethoxy-derivative 22 in 74% yield, while the reaction with 0.5 equivalents of benzaldehyde in ethanol resulted in bisindolylmethane derivative 23 in moderate yield (Scheme 7). NMR monitoring of the reaction revealed, that after first few hours both indoles 22 and 23 can be found in the reaction mixture. Further heating led to decreasing of the amount of 22, while the amount of 23 showed increase. Based on that fact, we rationalized possible mechanism of formation of 23 as follows. At first step, 4a reacts with aldehyde to form 22, which is protonated by strong methanesulfonic acid to give oxonium salt 24. Friedel–Crafts alkylation of indole 4a by this oxonium salt afforded bisindolylmethane derivative 23.
It should be noted that a lot of attention has been paid to the elaboration of novel strategies for the synthesis of bisindolylmethane derivatives, because many of them exhibit a various kinds of physiological activity [96,97,98,99]. Thus, bisindolylmethanes revealed properties of antibacterial, antifungal, antimicrobial, anti-inflammatory and anti-cancer agents [100,101,102,103,104,105]. In addition, this structural unit can be found in the natural sources, for example in marine alkoloids [106,107,108]. To the best of our knowledge fluorinated bisindolylmethanes have not been reported to date. We believe that our approach to these compounds can be useful in design of potentially active physiologically active compounds.

3. Materials and Methods

General remarks.1H, 13C and 19F NMR spectra were recorded on Bruker AVANCE 400 MHz spectrometer in CD3CN, DMSO-d6 and CDCl3 at 400, 100 and 376 MHz, respectively. Chemical shifts (δ) in ppm are reported with the use of the residual CHD2CN, DMSO-d5 and chloroform signals (1.94, 2.54 and 7.25 for 1H and 1.30, 39.5 77.0 for 13C) as internal reference. The 19F chemical shifts were referenced to C6F6, (−162.9 ppm). The coupling constants (J) are given in Hertz (Hz). ESI-MS spectra were measured at MicroTof Bruker Daltonics instrument. TLC analysis was performed on “Merck 60 F254” plates. Column chromatography was performed on silica gel. All reagents were of reagent grade and were used as such or were distilled prior to use. β-Chloro-β-trifluoromethylstyrenes 1 were prepared as reported previously by catalytic olefination reaction [89,90] or by Wittig reaction [109]. Melting points were determined on an Electrothermal 9100 apparatus.
Synthesis of styrenes 2 by catalytic olefination reaction in EtOH or DMSO (general procedure I, 5 mmol scale) [90]. One neck 100 mL round bottomed flask was charged with N2H4·H2O (0.265 g, 5.25 mmol), and solution of corresponding benzaldehyde (5 mmol in 25 mL of EtOH or DMSO) was added and stirred for 3 h until aldehyde disappeared (TLC control). Next, 1,2-ethylenediamine (0.65 mL, 7.5 mmol), CuCl (0.050 g, 0.5 mmol) were added and stirred for 1–2 min. After that CF3CCl3 (1.78 mL, 15 mmol) was added in one portion at cooling by cold water bath. Reaction mixture stirred overnight at room temperature, poured into water (100 mL) and extracted with CH2Cl2 (3 × 20 mL). Combined extract was washed with water (20 mL) and dried over Na2SO4. Solvents were evaporated in vacuo, the residue was purified by passing through a short silica gel pad using 3:1 mixture of hexane and CH2Cl2 as an eluent.
Synthesis of styrenes 2 by catalytic olefination reaction in ethylene glycol (general procedure II) [89]. One neck 50 mL round bottomed flask was charged with 1 mmol of corresponding benzaldehyde, 10 mL of ethylene glycol, 0.25 mL (5 mmol) of N2H4·H2O and stirred 0.5–1h until aldehyde disappeared (TLC control). Next, 0.38 mL (4.4 mmol) of 1,2-ethylenediamine, 0.0086 g (0.05 mmol) of CuCl2·2H2O was added and stirred for 1–2 min. After that CF3CCl3 (0.71 mL, 6 mmol) was added in one portion at cooling by cold water bath. Reaction mixture stirred overnight at room temperature, poured into water (50 mL) and extracted with CH2Cl2 (3 × 20 mL). Combined extract was washed with water (20 mL) and dried over Na2SO4. Solvents were evaporated in vacuo, the residue was purified by passing through a short silica gel pad using 3:1 mixture of hexane and CH2Cl2 as an eluent.
Synthesis of styrene 2a by catalytic olefination reaction in EtOH (150 mmol scale). One neck 1000 mL round bottomed flask was charged with N2H4·H2O (5.25 g, 105 mmol), and solution of 2-nitrobenzaldehyde (15.11 g, 100 mmol in 175 mL of EtOH) was added at vigorous stirring. The reaction mixture was stirred for 3 h until aldehyde disappeared (TLC control). Next, 1,2-ethylenediamine (10 mL, 150 mmol), CuCl (1 g, 10 mmol) were added and stirred for 1–2 min. After that CF3CCl3 (18 mL, 150 mmol) was added in one portion at cooling by cold water bath. The reaction mixture stirred overnight at room temperature, poured into HCl water solution (1000 mL, ~0.4–0.5 M) and extracted with CH2Cl2 (3 × 150 mL). Combined extract was washed with water (200 mL) and dried over Na2SO4. Solvents were evaporated in vacuo, the residue was purified by passing through a short silica gel pad (~120–150 cm3 of silica gel) using 3:1 mixture of hexane as an eluent. Evaporation of the solvents afforded pure 2a as slightly yellow oil. Yield 17.1 g (68%).
Synthesis of styrenes 2 by Wittig reaction (general procedure III, 5 mmol scale) [109]. One neck 20 mL vial with a screw cap was charged with corresponding benzaldehyde (2 mmol), PPh3 (1.258 g, 4.8 mmol), K2CO3 (0.028 g, 0.2 mmol), MeCN (2 mL) and CF3CCl3 (0.561 g, 3 mmol). The reaction mixture was stirred for 3–5 h at 80 °C and then poured into water (100 mL) and extracted with CH2Cl2 (3 × 20 mL). Combined extract was washed with water (20 mL) and dried over Na2SO4. Solvents were evaporated in vacuo, the residue was purified by column chromatography on silica gel using 3:1 (2b,g,i,k,n) and 1:1 (2j,l,m) mixtures of hexane and CH2Cl2 as eluents.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2-nitrobenzene (2a). Obtained from 2-nitrobenzaldehyde. Obtained from 2-nitrobenzaldehyde 1a (0.151 g, 1 mmol) by procedure II. Сolorless oil, yield 0.223 g (88%). Mixture of Z/E isomers (82:18; by 19F NMR). NMR data of styrene 2a (see Supplementary Materials) are in agreement with those in the literature [110].
4-Chloro-1-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2-nitrobenzene (2b). Obtained from 4-chloro-2-nitrobenzaldehyde 1b (0.185g, 1 mmol) by procedure II. Light yellow oil, yield 0.223 g (78%). Mixture of Z/E isomers (90:10; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 8.21 (d, 1H, 4J = 2.1 Hz), 7.75–7.67 (m, 2H), 7.61 (d, 1H, 3J = 8.3 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.6, 136.4, 133.9, 132.4, 128.2 (q, 3JCF = 4.8 Hz), 125.9, 125.4, 123.4 (q, 2JCF = 38.0 Hz), 120.2 (q, 1JCF = 272.8 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −70.4 (d, 3F, 4J = 1.0 Hz). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.65 (dd, 1H, 3J = 8.3 Hz, 4J = 2.2 Hz), 7.46 (s, 1H), 7.32 (d, 1H, 3J = 8.3 Hz). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 136.2, 133.8, 132.1, 126.8, 125.2. Other signals are overlapped with those of major isomer or cannot be seen in the spectrum due to the low concentration of minor isomer. 19F NMR (CDCl3, 376.5 MHz): δ −63.2 (s, 3F). HRMS (ESI-TOF): m/z [M + Ag]+ Calcd for C9H4Cl2F3NO2Ag+: 393.8610; found: 393.8619.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-3-methoxy-2-nitrobenzene(2c). Obtained from 3-methoxy-2-nitrobenzaldehyde 1c (0.188 g, 1.039 mmol) by procedure II. Yellow crystals, mp 42–44 °С, yield 0.211 g (75%). Mixture of Z/E isomers (76:24; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.50 (t, 1Н, 3J = 8.2 Hz), 7.34 (d, 1Н, 3J = 7.8 Hz), 7.24 (s, 1H), 7.13 (d, 1Н, 3J = 8.5 Hz), 3.91 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 151.26, 140.4, 131.43, 125.4, 125.0 (q, 3JCF = 4.5 Hz), 124.9 (q, 2JCF = 37.6 Hz), 121.0, 120.1 (q, 1JCF = 273.9 Hz), 114.0, 56.51. 19F NMR (CDCl3, 376.5 MHz): δ −70.3 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.43 (t, 1Н, 3J = 8.2 Hz), 7.17 (s, 1H), 7.08 (d, 1Н, 3J = 8.5 Hz), 6.86 (d, 1Н, 3J = 7.8 Hz), 3.90 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 151.24, 139.2, 131.48, 130.0 (q, 3JCF = 2.1 Hz), 126.8, 125.3 (q, 2JCF = 37.6 Hz), 120.8 (q, 4JCF = 2.5 Hz), 119.8 (q, 1JCF = 273.9 Hz), 113.4, 56.46. 19F NMR (CDCl3, 376.5 MHz): δ −63.6 (s, 3F). HRMS (ESI-TOF): m/z [M + NH4]+ Calcd for C10H11ClF3N2O3+: 299.0405; found: 299.0404.
2-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-4-methoxy-1-nitrobenzene(2d). Obtained from 5-methoxy-2-nitrobenzaldehyde 1d (0.183 g, 1.011 mmol) by procedure II. Yellow oil, yield 0.234 g (82%). Mixture of Z/E isomers (84:16; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 8.25–8.21 (m, 1H), 7.75 (s, 1H), 7.05–6.99 (m, 2H), 3.92 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 163.6, 140.0, 130.1 (q, 3JCF = 4.8 Hz), 130.0, 127.7, 120.4 (q, 1JCF = 272.6 Hz), 121.9 (q, 2JCF = 37.7 Hz), 116.2, 114.7, 56.1. 19F NMR (CDCl3, 376.5 MHz): δ −70.2 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 8.20 (d, 1H, 3J = 6.6 Hz), 7.51 (s, 1H), 6.97 (d, 1H, 3J = 2.8 Hz), 6.77 (d, 1H, 3J = 2.7 Hz), 3.90 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 163.5, 139.2, 134.1 (q, 3JCF = 2.3 Hz), 130.9, 127.5, 120.1 (q, 1JCF = 274.2 Hz), 121.2 (q, 2JCF = 37.5 Hz), 115.9 (q, 3JCF = 2.6 Hz), 114.5, 56.04. 19F NMR (CDCl3, 376.5 MHz): δ −63.0 (s, 3F). HRMS (ESI-TOF): m/z [M + Na]+ Calcd for C10H7ClF3NO3Na+: 303.9959; found: 303.9957.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-3,5-dimethyl-2-nitrobenzene (2e). Obtained from 3,5-dimethyl-2-nitrobenzaldehyde 1e (0.174 g, 0.972 mmol) by procedure II. Yellow oil, yield 0.214 g (77%). Mixture of Z/E isomers (78:22; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.36 (s, 1H), 7.31 (s, 1H), 7.17 (s, 1H), 2.40 (s, 3H), 2.36 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.8, 141.5, 133.4, 131.4, 128.1, 126.8 (q, 3JCF = 4.6 Hz), 124.9, 123.7 (q, 2JCF = 37.5 Hz), 120.2 (q, 1JCF = 272.7 Hz), 21.1, 18.2. 19F NMR (CDCl3, 376.5 MHz): δ −70.3 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.23 (s, 1H), 7.13 (s, 1H), 6.94 (s, 1H). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 146.6, 141.6, 133.1, 131.8 (q, 3JCF = 2.3 Hz), 131.6, 127.9 (q, 4JCF = 2.4 Hz), 126.4, 123.8 (q, 2JCF = 37.4 Hz), 119.9 (q, 1JCF = 274.5 Hz), 20.9, 18.3. 19F NMR (CDCl3, 376.5 MHz): δ −63.5 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H10ClF3NO2+: 280.0347; found: 280.0641.
6-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine (2f). Obtained from 7-nitro-2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde 1f (0.212 g, 1.014 mmol) by procedure II. Pale yellow crystals, mp 104–106 °С, yield 0.241 g (78%). Mixture of Z/E isomers (80:20; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.81 (s, 1H), 7.68 (pseudo-d, 1H, 4J = 0.8 Hz), 7.10 (s, 1H), 4.45–4.28 (m, 4H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 148.2, 143.9, 129.2 (q, 3JCF = 4.6 Hz), 121.5, 121.4 (q, 2JCF = 37.5 Hz), 120.5 (q, 1JCF = 272.3 Hz), 119.3, 115.0, 64.7, 64.3. 19F NMR (CDCl3, 376.5 MHz): δ −70.2 (d, 3F, 4J = 1.0 Hz). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.80 (s,1H), 7.43 (pseudo-d, 1H, 4J = 0.8 Hz), 6.79 (s, 1H). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 143.8, 140.5, 133.8 (q, 3JCF = 2.3 Hz), 122.6, 121.5 (q, 2JCF = 37.3 Hz), 120.2 (q, 1JCF = 274.1 Hz), 119.0 (q, 3JCF = 2.5 Hz), 114.8, 64.2. Other signals are overlapped with those of major isomer or cannot be seen in the spectrum due to the low concentration of minor isomer. 19F NMR (CDCl3, 376.5 MHz): δ −63.1 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H8ClF3NO4+: 310.0088; found: 310.0086.
2-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-1,4-dimethoxy-3-nitrobenzene(2g). Obtained from 1,4-dimethoxy-3-nitrobenzaldehyde 1g (0.222 g, 1.052 mmol) by procedure II. Pale yellow crystals, mp 72–73 °С, yield 0.254 g (78%). Mixture of Z/E isomers (91:9; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.18 (s, 1H), 7.07 (d, 1H, 3J = 9.3 Hz), 7.03 (d, 1H, 3J = 9.2 Hz), 3.87 (s, 3H), 3.83 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 150.2, 145.1, 126.8 (q, 2JCF = 37.8 Hz), 124.0 (q, 3JCF = 4.6 Hz), 119.9 (q, 1JCF = 272.9 Hz), 115.4, 114.4, 113.9, 57.0, 56.5. 19F NMR (CDCl3, 376.5 MHz): δ −70.3 (d, 3F, 4J = 1.0 Hz). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 6.99 (d, 1H, 3J = 3.2 Hz), 6.98 (d, 1H, 3J = 3.2 Hz), 6.88 (s, 1H), 3.85 (s, 3H), 3.79 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 144.7, 140.4, 113.3, 56.9, 56.3. Other signals are overlapped with those of major isomer or cannot be seen in the spectrum due to the low concentration of minor isomer. 19F NMR (CDCl3, 376.5 MHz): δ −67.8 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H10ClF3NO4+: 312.0245; found: 312.0251.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-4,5-dimethoxy-2-nitrobenzene(2h). Obtained from 2,5-dimethoxy-3-nitrobenzaldehyde 1h by procedure I (0.539 g, 2.55 mmol, DMSO) and by procedure II (0.245 g, 1.161 mmol). Pale yellow solid, mp 95–97 °С, yield 0.374 g (47%, I) yield 0.128 g (43%, II). Mixture of Z/E isomers (80:20; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.79–7.74 (m, 2H), 7.02 (s, 1H), 3.99 (s, 3H), 3.99 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 153.2, 149.4, 140.1, 129.9 (q, 3JCF = 4.7 Hz), 121.6, 121.4 (q, 2JCF = 37.3 Hz), 120.4 (q, 1JCF = 272.4 Hz), 112.1, 107.7, 56.6, 56.40. 19F NMR (CDCl3, 376.5 MHz): δ −70.1 (d, 3F, 4J = 1.0 Hz). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.52 (pseudo-d, 1H, 4J = 0.6 Hz), 6.71 (s, 1H), 3.97 (s, 3H), 3.95 (s, 3H). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 149.3, 138.9, 134.3 (q, 3JCF = 2.3 Hz), 122.7, 120.2 (q, 1JCF = 274.3 Hz), 121.1 (q, 2JCF = 37.2 Hz), 112.1, 107.5, 56.5, 56.38. 19F NMR (CDCl3, 376.5 MHz): δ −62.8 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H10ClF3NO4+: 312.0245; found: 312.0254.
5-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-6-nitrobenzo[d][1,3]dioxole (2i). Obtained from 4,5-ethylendioxy-2-nitrobenzaldehyde 1i (0.207 g, 1.062 mmol) by procedure II. Pale yellow solid, mp 100–103 °С, yield 0.155 g (52%). Mixture of Z/E isomers (79:21; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.68–7.66 (m, 2H), 6.99 (s, 1H). 6.19 (s, 2H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 152.22, 148.9, 141.8, 129.7 (q, 3JCF = 4.8 Hz), 123.9, 121.8 (q, 2JCF = 37.5 Hz), 120.4 (q, 1JCF = 272.5 Hz), 109.6, 105.7, 103.64. 19F NMR (CDCl3, 376.5 MHz): δ −70.2 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.65 (s, 1H), 7.43 (d, 1Н, 4J = 0.6 Hz), 6.70 (s, 1H), 6.17 (s, 2H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 152.19, 148.8, 140.6, 134.0 (q, 3JCF = 2.8 Hz), 124.9, 121.3 (q, 2JCF = 37.4 Hz), 120.1 (q, 1JCF = 274.5 Hz), 109.5 (q, 4JCF = 2.8 Hz), 105.4, 103.62. 19F NMR (CDCl3, 376.5 MHz): δ −63.2 (s, 3F). HRMS (ESI-TOF): m/z [M + Na]+ Calcd for C10H5ClF3NO4Na+: 317.9751; found: 317.9752.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,4-dinitrobenzene (2j). Obtained from 2,4-dinitrobenzaldehyde by procedure (II, 0.196 g) and (III, 0.65 g). Yellow viscous oil, yield 0.014 g (5%, II), 0.248 (25%, (III). Mixture of Z/E isomers (96:4; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 9.03 (pseudo-d, 1H, 4J ~ 1.5 Hz), 8.58 (dd, 1H, 3J = 8.5 Hz, 4J = 2.3 Hz), 7.91 (d, 1H, 3J = 8.5 Hz), 7.78 (s, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 148.1, 147.4, 140.2, 133.0, 127.9, 127.6 (q, 3JCF = 4.5 Hz), 125.0 (q, 2JCF = 38.0 Hz), 120.6, 119.9 (q, 1JCF = 273.2 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −69.4 (d, 3F, 4J = 0.6 Hz). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.78 (br.s, 1H), 8.52 (dd, 1H, 3J = 8.5 Hz, 4J = 2.3 Hz), 7.64 (d, 1H, 3J = 8.5 Hz), 7.53 (s, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): 127.0. Other signals are overlapped with those of major isomer or cannot be seen in the spectrum due to the low concentration of minor isomer. 19F NMR (CDCl3, 376.5 MHz): δ −62.2 (s, 3F). HRMS (ESI-TOF): m/z [M-H]- Calcd for C9H3ClF3N2O4: 294.9739; found: 294.9732.
1-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2-nitro-4-(trifluoromethyl)benzene (2k). Obtained from 2-nitro-4-(trifluoromethyl)benzaldehyde 1k by procedure II (0.438 g, 2 mmol) and by procedure III (0.438 g, 2 mmol). Yellow oil, yield 0.395 g (62%, II), 0.365 g (57%, III). Mixture of Z/E isomers (92:8; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 8.49 (pseudo-d, 1H, 4J ~ 1.0 Hz), 7.99 (dd, 1H, 3J = 8.0 Hz, 4J = 0.7 Hz), 7.81 (d, 1H, 3J = 8.1 Hz), 7.77 (s, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.2, 132.8 (q, 2JCF = 34.6 Hz), 132.4, 131.12, 130.3 (q, 3JCF = 3.4 Hz), 128.2 (q, 3JCF = 4.8 Hz), 124.3 (q, 2JCF = 38.1 Hz), 122.53 (q, 3JCF = 3.8 Hz), 122.46 (q, 1JCF = 273.1 Hz), 120.1 (q, 1JCF = 272.8 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −69.5 (s, 3F), −63.3 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.94 (dd, 1H, 3J = 8.0 Hz, 4J = 0.7 Hz), 7.56 (s, 1H), 7.53 (d, 1H, 3J = 8.2 Hz). Other signals are overlapped with those of major isomer. 19F NMR (CDCl3, 376.5 MHz): δ −62.3 (s, 3F). Other signals are overlapped with those of major isomer. HRMS (ESI-TOF): m/z [M + Ag]+ Calcd for C10H4ClF6NO2Ag+: 425.8880; found: 425.8874.
4-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-3-nitrobenzonitrile (2l). Obtained from 4-cyano-2-nitrobenzaldehyde 1l by procedure II (0.176 g, 1 mmol) and by procedure III (0.88 g, 5 mmol). Yellow oil, yield 0.070 g (25%) (II), 0.278 g (20%, III). Mixture of Z/E isomers (96:4; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz): δ
δ 8.51 (d, 1H, 4J = 1.6 Hz), 8.01 (dd, 1H, 3J = 8.1 Hz, 4J = 1.6 Hz), 7.81 (d, 1H, 3J = 8.1 Hz), 7.75 (s, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.1, 136.6, 132.5, 131.7, 128.7, 127.9 (q, 3JCF = 4.7 Hz), 124.3 (q, 2JCF = 38.5 Hz), 119.8 (q, 1JCF = 273.0 Hz, CF3), 115.9, 114.4. 19F NMR (CDCl3, 376.5 MHz): δ −70.5 (s, 3F). E-isomer: 1H NMR (CDCl3, 400.1 MHz): δ 7.95 (dd, 1H, 3J = 8.0 Hz, 4J = 1.6 Hz), 7.50 (s, 1H). Other signals are overlapped with those of major isomer. 19F NMR (CDCl3, 376.5 MHz): δ −63.3 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C10H5ClF3N2O2+: 276.9986; found: 276.9986.
Methyl 4-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-3-nitrobenzoate (2m). Obtained from methyl 4-formyl-3-nitrobenzoate 1m by procedure II (0.209 g, 1 mmol) and by procedure III (0.209 g, 1 mmol). Beige crystals, yield 0.040 g (13%, II), 0.079 g (22%, III). Mixture of Z/E isomers (95:5; by 19F NMR). 1H NMR (CDCl3, 400.1 MHz):
δ 8.81 (d, 1H, 4J = 1.7 Hz), 8.35 (dd, 1H, 3J = 8.0 Hz, 4J = 1.7 Hz), 7.76 (s, 1H), 7.73 (d, 1H, 3J = 8.1 Hz), 3.99 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 164.3, 147.2, 134.2, 132.4, 131.7, 131.4, 128.6 (q, 3JCF = 4.7 Hz), 126.1, 123.7 (q, 2JCF = 38.0 Hz), 120.1 (q, 1JCF = 272.9 Hz), 53.0. 19F NMR (CDCl3, 376.5 MHz): δ −70.4 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H8ClF3NO4+: 310.0088; found: 310.0085.
4-Chloro-2-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-1-nitrobenzene (2n). Obtained from 5-chloro-2-nitrobenzaldehyde 1n (0.191g, 1.03 mmol) by procedure II. Yellow crystals, mp 46–48 °С, yield 0.221 g (75%). Mixture of Z/E isomers (91:9; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 8.19 (d, 1Н, 3J = 8.8 Hz), 7.70 (s, 1H), 7.61 (d, 1Н, 4J = 2.1 Hz), 7.58–7.55 (m, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 145.3, 140.4, 131.1, 130.3, 129.2, 128.3 (q, 3JCF = 4.8 Hz), 126.5, 123.4 (q, 2JCF = 38.0 Hz), 120.1 (q, 1JCF = 272.9 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −70.5 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 7.46 (s, 1H). Other signals are overlapped with those of major isomer. 19F NMR (CDCl3, 376.5 MHz): δ −63.3 (s, 3F). HRMS (ESI-TOF): m/z [M + Ag]+ Calcd for C9H4Cl2F3NO2Ag+: 395.8583; found: 395.8587.
2-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-4-fluoro-1-nitrobenzene (2o). Obtained from 5-fluoro-2-nitrobenzaldehyde 1o (0.175g, 1.04 mmol) by procedure II. White crystals, mp 35–38 °С, yield 0.204 g (73%). Mixture of Z/E isomers (83:17; by 19F NMR). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 8.28 (dd, 1Н, 3J = 9.1 Hz, 3J = 5.1 Hz), 7.73 (s, 1H), 7.34 (dd, 1Н, 3J = 8.5 Hz, 4J = 2.6 Hz), 7.31–7.25 (m, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 164.9 (d, 1JCF = 259.2 Hz), 143.3 (d, 4JCF = 2.5 Hz), 130.6 (d, 3JCF = 10.0 Hz), 128.5 (qd, 3JCF = 4.5 Hz, 4JCF = 0.9 Hz), 128.1 (d, 3JCF = 10.2 Hz), 123.4 (q, 2JCF = 37.9 Hz), 120.2 (q, 1JCF = 272.8 Hz), 118.4 (d, 2JCF = 25.1 Hz), 117.3 (d, 2JCF = 23.1 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −70.5 (s, 3F), −102.55–−102.71 (m, 1F). E- isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 7.48 (s, 1H), 7.25–7.22 (m, 1H) 7.07 (dd, 1Н, 3J = 8.2 Hz, 4J = 2.7 Hz). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 164.7 (d, 1JCF = 259.8 Hz), 142.4, 132.3 (br.s), 131.4 (d, 3JCF = 9.9 Hz), 127.9 (d, 3JCF = 10.2 Hz), 122.6 (q, 2JCF = 37.5 Hz), 120.0 (q, 1JCF = 274.4 Hz), 116.9, 118.0 (q, 4JCF = 2.4 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −63.3 (s, 3F), −102.73–−102.88 (m, 1F). HRMS (ESI-TOF): m/z [M-F]+ Calcd for C9H4ClF3NO2+: 249.9877; found: 249.9873.
Synthesis of α-CF3-β-(2-nitroaryl)enamines by the reaction with pyrrolidine in neat (general procedure) [78]. A one neck 25 mL round bottomed flask was charged with dry pyrrolidine (8.5 mL, 100 mmol), cooled down to −18 °C and corresponding styrene 2 (10 mmol) was added in one portion with vigorous stirring. The reaction mixture was stirred at room temperature for 1–3 h until all starting styrene was consumed (TLC or NMR monitoring). The excess of pyrrolidine was evaporated in vacuum, the viscous residue was dissolved in CH2Cl2 (50 mL), washed with water (3 × 50 mL) and dried over Na2SO4. CH2Cl2 was removed in vacuo, and the residue was filtered through a short silica gel pad using appropriate mixture 1:1 of hexane and CH2Cl2.
1-[(1Z)-2-(2-Nitrophenyl)-1-(trifluoromethyl)vinil]pyrrolidine (3a). Obtained from 1-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2-nitrobenzene 2a (6.04 g, 24 mmol). Yellow oil, yield 6.733 g (98%). Mixture of Z/E isomers (86:14; 19F NMR). NMR data of enamine 3a (see Supplementary Materials) are in agreement with those in the literature [78].
1-[(1Z)-2-(3-Methoxy-2-nitrophenyl)-1-(trifluoromethyl)vinil]pyrrolidine (3c). Obtained from 1-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-3-methoxy-2-nitrobenzene 2c (0.211 g, 0.75 mmol). Orange oil, yield 0.190 g (80%). Mixture of Z/E isomers (84:16; 19F NMR). NMR data of enamine (see Supplementary Materials) are in agreement with those in the literature [84].
1-Hydroxy-7-methoxy-2-(pyrrolidin-1-yl)-2-(trifluoromethyl)indolin-3-one (5c). Obtained from 1-[2-chloro-3,3,3-trifluoro-1-propenyl]-3-methoxy-2-nitrobenzene 2c as an admixture in the synthesis of enamine 3c. Orange oil, yield 0.036 g (15%). 1H NMR (CDCl3, 400.1 MHz):
δ 7.74 (s, 1H), 7.24–7.28 (m, 1H), 7.01–7.15 (m, 2H), 3.90 (s, 3H), 3.11 (dd, 2Н, 3J = 7.2 Hz), 2.95 (q, 2Н, 3J = 6.9 Hz), 1.78 (t, 4Н, 3J = 6.2 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 192.4, 152.3, 149.3, 124.9, 122.6, 122.4 (q, 1JCF = 284.8 Hz), 118.9, 115.6, 86.4 (q, 2JCF = 28.1 Hz), 55.9, 47.8, 24.4. 19F NMR (CDCl3, 376.5 MHz): δ −73.6 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C14H16F3N2O3+: 317.1108; found: 317.1109.
1-[(1Z)-2-(5-methoxy-2-nitrophenyl)-1-(trifluoromethyl)vinil]pyrrolidine (3d). Obtained from 2-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-4-methoxy-1-nitrobenzene 2d (0.976 g, 3.465 mmol). Orange oil, yield 1.074 g (98%). Mixture of Z/E isomers (86:14; 19F NMR). NMR data of enamine 3d (see Supplementary Materials) are in agreement with those in the literature [84].
1-[(1Z)-(4-nitro-3-(3,3,3-trifluoro-2-(pyrrolidin-1-yl)prop-1-en-1-yl)phenyl]pyrrolidine (3n). Obtained from styrenes 2n (0.286 g, 1 mmol) or from styrene 2o (0.396 g, 1.469 mmol). Yellow orange solid, mp 145–147 °С, yield 0.255 g (72% from 2n), 0.468 g (90% from 2o). Mixture of Z/E isomers (84:16; 19F). For the mixture of isomers: Z-isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 8.07 (d, 1Н, 3J = 9.3 Hz), 6.39–6.33 (m, 2Н), 6.20 (d, 1H, 4J = 2.4 Hz), 3.39–3.30 (m, 4Н), 3.02 (t, 4Н, 3J = 6.4 Hz), 2.11–2.02 (m, 4Н), 1.69–1.80 (m, 4Н). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 150.2, 135.8, 135.0, 133.9 (q, 2JCF = 28.7 Hz), 127.7, 121.9 (q, 1JCF = 277.8 Hz), 112.9, 109.21, 104.1 (q, 3JCF = 6.8 Hz), 50.4 (d, 4JCF = 1.1 Hz), 47.7, 25.4, 25.3. 19F NMR (CDCl3, 376.5 MHz): δ −65.8 (s, 3F). E- isomer: 1H NMR (CDCl3, 400.1 MHz):
δ 8.08 (d, 1Н, 3J = 9.3 Hz), 5.97 (s, 1Н), 6.27 (d, 1H, 4J = 2.4 Hz), 3.24 (t, 4Н, 3J = 6.5 Hz), 1.97–1.90 (m, 4Н). Other signals are overlapped with those of major isomer. 13C{1H} NMR (CDCl3, 100.6 MHz): δ 135.5 (q, 2JCF = 27.3 Hz), 127.6, 113.8 (q, J = 3.4, CH = CCF3), 109.24, 106.2 (q, 3JCF = 3.4 Hz), 49.30 (d, 4JCF = 1.1 Hz), 47.6, 24.6. Other signals are overlapped with those of major isomer or cannot be seen in the spectrum due to the low concentration of minor isomer. 19F NMR (CDCl3, 376.5 MHz): δ −59.2 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C17H21F3N3O2+: 356.1580; found: 356.1581.
Synthesis of indoles 4 by the reduction of nitro-substituted enamines 3 (general procedure IV). A one neck 25 mL round bottomed flask was charged with enamine 3 (0.5 mmol), glacial acetic acid (2 mL), water (0.2 mL) and Fe powder (0.112 g, 2 mmol). Reaction mixture was kept at 80 °С under stirring for 1–2 h until dissolving of Fe powder. Volatiles were evaporated in vacuo, the residue was suspended in CH2Cl2 (2–5 mL) and transferred on the short silica gel pad. The product was isolated using appropriate mixture of hexane and CH2Cl2 (3:1 for 4a, 4d); and mixture of CH2Cl2 and MeOH (100:1 for 4o) as eluents.
Multi-gram scale synthesis of indole 4a. A one neck 250 mL round bottomed flask was charged with enamine 3a (7.01 g, 24.5 mmol), glacial acetic acid (100 mL), water (20 mL) and Fe powder (5.49 g, 98 mmol). Reaction mixture was kept at 80–90 °С under stirring for 2 h until dissolving of Fe powder. The reaction mixture was poured into water (1000 mL), the precipitate formed was filtered off and washed by water (100 mL). Next, precipitate was washed with CH2Cl2 (2 × 50 mL), organic phase was dried over Na2SO4 and evaporated in vacuo to give pure indole 4a as colorless plates.
One pot synthesis of indoles 4 from styrenes 2 (general procedure V). A one neck 25 mL round bottomed flask was charged with pyrrolidine (1 mL, 11.8 mmol) and corresponding styrene 2 (0.5 mmol) was added in one portion with vigorous stirring. The reaction mixture was stirred at room temperature for 1–3 h until all starting styrene was consumed (TLC or NMR monitoring). The excess of pyrrolidine was evaporated in vacuum and the viscous residue was dissolved in glacial acetic acid (2 mL) and water (0.2 mL). After that Fe powder (0.112 g, 2 mmol) was added and the reaction mixture was kept at 80 °С under stirring for 1–2 h until dissolving of Fe powder. Volatiles were evaporated in vacuo, the residue was suspended in CH2Cl2 (2–5 mL) and transferred on the short silica gel pad. The product was isolated using appropriate mixtures of hexane and CH2Cl2 (3:1 for 4b,4c,4e,4k,4n; 1:1 for 4f,4g,4h,4i); CH2Cl2 (for 4l,4m) and mixture of CH2Cl2 and MeOH (100:1 for 4j,4o) as eluents.
2-(Trifluoromethyl)-1H-indole (4a). Obtained from enamine 3a (0.107 g, 0.374 mmol) by procedure IV. White crystals, m.p. 111–112 °C, yield 0.059 g (85%). NMR data of indole 4a (see Supplementary Materials) are in agreement with those in the literature [67].
6-Chloro-2-(trifluoromethyl)-1H-indole (4b). Obtained from styrene 2b (0.100 g, 0.35 mmol) by procedure V. Slightly yellow oil, yield 0.035 g (48%). NMR data of indole 4b (see Supplementary Materials) are in agreement with those in the literature [67].
7-Methoxy-2-(trifluoromethyl)-1H-indole (4c). Obtained from styrene 2c (0.149 g, 0.53 mmol) by procedure V. Colorless oil, yield 0.058 g (51%). NMR data of indole 4c (see SI) are in agreement with those in the literature [67].
5-Methoxy-2-(trifluoromethyl)-1H-indole (4d). Obtained from enamine 3d (0.088 g, 0.28 mmol) by procedure IV. Colorless crystals, m.p. 48–49 °C, yield 0.0382 g (64%). NMR data of indole 4d (see Supplementary Materials) are in agreement with those in the literature [67].
5,7-Dimethyl-2-(trifluoromethyl)-1H-indole (4e). Obtained from styrene 2e (0.109 g, 0.391 mmol) by procedure V. Slightly yellow oil, yield 0.036 g (43%). 1H NMR (CDCl3, 400.1 MHz): δ 8.16 (br.s, 1H), 7.30 (s, 1Н), 6.96 (s, 1Н), 6.88–6.82 (m, 1Н), 2.48 (s, 3H), 2.42 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 134.3, 130.7, 127.0, 126.5, 125.4 (q, 2JCF = 38.9 Hz), 121.4 (q, 1JCF = 267.4 Hz), 120.6, 119.0, 104.3 (q, 3JCF = 3.4 Hz), 21.3, 16.5. 19F NMR (CDCl3, 376.5 MHz): δ −61.6 (d, 3F, 4J = 1.0 Hz). HRMS (ESI-TOF): m/z [M-H]- Calcd for C11H9F3N: 212.0693; found: 212.0690.
7-(Trifluoromethyl)-2,3-dihydro-6H-[1,4]dioxino[2,3-f]-indole (4f). Obtained from styrene 2f (0.154 g, 0.497 mmol) by procedure V. White powder, m.p. 136–138 °C, yield 0.098 g (81%). 1H NMR (CDCl3, 400.1 MHz): δ 8.24 (br.s, 1H), 7.13 (s, 1Н), 6.87 (s, 1Н), 6.77 (s, 1Н), 4.28 (q, 4Н, 3J = 5.2 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 143.1, 140.1, 131.7, 125.5 (q, 2JCF = 38.9 Hz), 121.2 (q, 1JCF = 267.3 Hz), 121.0, 107.9, 103.8 (q, 3JCF = 3.4 Hz), 98.6, 64.5, 64.1. 19F NMR (CDCl3, 376.5 MHz): δ −61.5 (s, 3F). HRMS (ESI-TOF): m/z [M-H]- Calcd for C11H7F3NO2: 242.0434; found: 242.0437.
4,7-Dimethoxy-2-(trifluoromethyl)-1H-indole (4g). Obtained from styrene 2g (0.107 g, 0.309 mmol) by procedure V. Light beige crystals, m.p. 74–76 °C, yield 0.053 g (70%). 1H NMR (CDCl3, 400.1 MHz): δ 8.73 (br.s, 1H), 7.05–7.01 (m, 1Н), 6.62 (d, 1Н, 3J = 8.3 Hz), 6.42 (d, 1Н, 3J = 8.3 Hz), 3.92 (s, 3H), 3.91 (s, 3H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 148.2, 140.9, 128.2, 124.3 (q, 2JCF = 39.5 Hz), 121.2 (q, 1JCF = 267.5 Hz), 119.0, 103.9, 102.2 (q, 3JCF = 3.3 Hz), 99.6, 55.7, 55.6. 19F NMR (CDCl3, 376.5 MHz): δ −61.4 (d, 3F, 4J = 0.9 Hz). HRMS (ESI-TOF): m/z [M]+ Calcd for C11H10F3NO2+: 245.0658; found: 245.0667.
5,6-Dimethoxy-2-(trifluoromethyl)-1H-indole (4h). Obtained from styrene 2h (0.129 g, 0.416 mmol) by procedure V. White crystals, m.p. 89–90 °C, yield 0.055 g (54%). NMR data of indole 4h (see Supplementary Materials) are in agreement with those in the literature [67].
6-(Trifluoromethyl)-5H-[1,3]dioxolo[4.5-f]-indole (4i). Obtained from styrene 2i (0.125 g, 0.38 mmol) by procedure V. White crystals, m.p. 113–115 °C, yield 0.022 g (25%). NMR data of indole 4i (see Supplementary Materials) are in agreement with those in the literature [74].
2-(Trifluoromethyl)-1H-indole-6-amine (4j). Obtained from styrene 2j (0.293 g, 0.99 mmol) by procedure V. 8 Equivalents of Fe (0.448 g, 8 mmol) was used due to the presence of second nitro-group in the styrene 2j. Beige crystals, m.p. 124–126 °C, yield 0.119 g (60%). NMR data of indole 4j (see Supplementary Materials) are in agreement with those in the literature [67].
2,6-Bis(trifluoromethyl)-1H-indole (4k). Obtained from styrene 2k (0.240 g, 0.75 mmol) by procedure V. Yellow crystals, m.p. 46–47 °C, yield 0.0896 g (47%). NMR data of indole 4k (see Supplementary Materials) are in agreement with those in the literature [67].
2-(Trifluoromethyl)-1H-indole-6-carbonitril (4l). Obtained from styrene 2l (0.080 g, 0.291 mmol) by procedure V. Slightly brown solid, m.p. 112–114 °C, yield 0.0305 g (50%). 1H NMR (CDCl3, 400.1 MHz): δ 9.18 (br.s, 1H), 7.85 (pseudo-d, 1Н, 4J ~ 1.1 Hz), 7.77 (d, 1Н, 3J = 8.3 Hz), 7.43 (dd, 1Н, 3J = 8.3 Hz, 4J = 1.3 Hz), 6.99 (pseudo-dt, 1Н, 4J ~ 2.1 Hz, 4J ~ 1.0 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 134.9, 129.7, 129.5 (q, 2JCF = 39.2 Hz), 123.7, 123.1, 120.6 (q, 1JCF = 268.6 Hz), 119.8, 117.0, 107.2, 104.4 (q, 3JCF = 3.2 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −62.2 (d, 3F, 4J = 0.9 Hz). HRMS (ESI-TOF): m/z [M-H]- Calcd for C10H4F3N2: 209.0332; found: 209.0323.
Methyl 2-(trifluoromethyl)-1H-indole-6-carboxylate (4m). Obtained from styrene 2m (0.126 g, 0.408 mmol) by procedure V. Pale brown solid, yield 0.0525 g (53%). NMR data of indole 4m (see Supplementary Materials) are in agreement with those in the literature [67].
5-Cloro-2-(trifluoromethyl)-1H-indole (4n). Obtained from styrene 2n (0.083 g, 0.29 mmol) by procedure V (piperidine was used instead of pyrrolidine). Pale yellow crystals, m.p. 59–61 °C, yield 0.0327 g (71%). NMR data of indole 4n (see Supplementary Materials) are in agreement with those in the literature [64].
5-(Pyrrolidin-1-yl)-2-(trifluoromethyl)-1H-indole (10a). Obtained from enamine 3n (0.160 g, 0.45 mmol) by procedure V. Orange crystals, m.p. 130–131 °C, yield 0.052 g (45%). 1H NMR (CDCl3, 400.1 MHz): δ 8.11 (br.s, 1H), 7.26 (d, 1Н, 3J = 9.1 Hz), 6.86–6.70 (m, 3Н), 3.32 (t, 4Н, 3J = 6.6 Hz), 2.09–2.00 (m, 4H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 143.9, 129.4, 127.9, 125.6 (q, 2JCF = 38.5 Hz), 121.4 (q, 1JCF = 267.5 Hz), 113.2, 112.1, 103.2 (q, 3JCF = 3.3 Hz), 101.7, 48.6, 25.3. 19F NMR (CDCl3, 376.5 MHz): δ −61.5 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C13H14F3N2+: 255.1104; found: 255.1109.
One pot synthesis of indoles 10 from styrenes 2 (general procedure VI). A 4 mL vial with a screw cup was charged with corresponding amine (5 mmol) and styrene 2n (0.5 mmol). The reaction mixture was heated at appropriate temperature for several hours (see further) or at room temperature (for MeNH2) until starting styrene was consumed (TLC or NMR monitoring). The excess of amine was evaporated in vacuo, the viscous residue was dissolved in glacial acetic acid (2 mL) and transferred into a one neck 25 mL round bottomed flask. Next, water (0.2 mL), Fe powder (0.112 g, 2 mmol) was added, and the reaction mixture was kept at 80 °С at stirring for 1–2 h until dissolving of Fe powder. Volatiles were evaporated in vacuo, the residue was suspended in CH2Cl2 (2–5 mL) and filtered through a short celite pad. The filtrate was evaporated, and the residue was purified by column chromatography on silica gel using appropriate mixtures of CH2Cl2 and MeOH (100:1 for 10b-e and 30:1 for 10f,g) as eluents.
5-(Piperidin-1-yl)-2-(trifluoromethyl)-1H-indole (10b). Obtained styrene 2n (0.109 g, 0.404 mmol) and piperidine (0.572 g) by heating at 90 °C for 3 h. Pale green-brown solid, m.p. 104–106 °C, yield 0.048 g (44%). 1H NMR (CDCl3, 400.1 MHz): δ 8.46 (br.s, 1H), 7.25 (d, 1Н, 3J = 8.9 Hz), 7.17 (pseudo-d, 1Н, 4J ~ 2.1 Hz), 7.12 (dd, 1Н, 3J = 8.9 Hz, 4J = 2.3 Hz), 6.82 (br.s, 1H), 3.14–3.07 (m, 4Н), 1.77 (dt, 4H, 3J = 11.3 Hz, 3J = 5.7 Hz), 1.62–1.54 (m, 2H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.9, 131.5, 127.2, 125.8 (q, 2JCF = 38.8 Hz), 121.3 (q, 1JCF = 267.6 Hz), 119.5, 112.1, 108.4, 103.9 (q, 3JCF = 3.4 Hz), 53.1, 26.2, 24.2. 19F NMR (CDCl3, 376.5 MHz): δ −61.4 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C14H16F3N2+: 269.1260; found: 269.1265.
4-(2-(Trifluoromethyl)-1H-indol-5yl)morpholine (10c). Obtained from styrene 2n (0.104 g, 0.385 mmol) and morpholine (0.530 g) by heating at 100 °C for 4 h. Pale green-brown solid, m.p. 167–169 °C, yield 0.061 g (59%). 1H NMR (CDCl3, 400.1 MHz):
δ 9.91 (br.s, 1Н), 7.42–7.36 (m, 1Н), 7.12–7.07 (m, 2Н), 6.84 (pseudo-dt, 1 H, 4J ~ 2.1 Hz, 4J ~ 1.0 Hz), 3.84–3.75 (m, 4H), 3.10–3.01 (m, 4H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 147.8, 133.0, 127.9, 126.3 (q, 2JCF = 38.6 Hz), 122.6 (q, 1JCF = 266.5 Hz), 118.9, 113.5, 107.8, 104.1 (q, 3JCF = 3.4 Hz), 67.6, 52.1. 19F NMR (CDCl3, 376.5 MHz): δ −59.5 (d, 3F, 4J = 1.0 Hz). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C13H14F3N2O+: 271.1053; found: 271.1057.
5-(Azepan-1-yl)-2-(trifluoromethyl)-1H-indole (10d). Obtained from styrene 2n (0.107 g, 0.396 mmol) and hexamethyleneimine (0.480 g) by heating at 100 °C for 4 h. Pale yellow-brown solid, m.p. 65–67 °C, yield 0.060 g (54%). 1H NMR (CDCl3, 400.1 MHz): δ 8.12 (br.s, 1Н), 7.23 (d, 1Н, 3J = 9.0 Hz), 6.92 (dd, 1Н, 3J = 9.0 Hz, 4J = 2.4 Hz), 6.88 (pseudo-d, 1 H, 4J ~ 2.2 Hz), 6.79 (br.s, 1H), 3.56–3.47 (m, 4H), 1.89–1.79 (m, 4H), 1.61–1.53 (m, 4H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 144.6, 129.1, 128.0, 125.6 (q, 2JCF = 38.7 Hz), 121.4 (q, 1JCF = 267.4 Hz), 112.9, 112.2, 103.3 (q, 3JCF = 3.1 Hz), 101.5, 50.0, 27.9, 27.1. 19F NMR (CDCl3, 376.5 MHz): δ −61.5 (d, 3F, 4J = 0.9 Hz). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C15H18F3N2+: 283.1417; found: 283.1424.
N,N-Diethyl-2-(trifluoromethyl)-1H-indole-5-amine (10e). Obtained from styrene 2n (0.101 g, 0.374 mmol) and diethylamine (0.480 g) by heating at 100 °C for 10 h. Pale brown oil, yield 0.041 g (43%). 1H NMR (CDCl3, 400.1 MHz): δ 8.29 (br.s, 1Н), 7.26 (d, 1Н, 3J = 8.7 Hz), 7.02–6.93 (m, 2Н), 6.79 (s, 1H), 3.33 (q, 4H, 3J = 7.1 Hz), 1.13 (t, 6H, 3J = 7.1 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 143.7, 130.3, 127.6, 125.7 (q, 2JCF = 38.9 Hz), 121.4 (q, 1JCF = 267.4 Hz), 116.4, 112.2, 106.0, 103.5 (q, 3JCF = 3.2 Hz), 45.9, 12.3. 19F NMR (CDCl3, 376.5 MHz): δ −61.6 (d, 3F, 4J = 1.1 Hz). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C13H16F3N2+: 257.1260; found: 257.1261.
N-Methyl-2-(trifluoromethyl)-1H-indole-5-amine (10f). Obtained from styrene 2n (0.116 g, 0.430 mmol) and n-methylamine (2 mL of 3.65 M solution in MeOH) by keeping the reaction mixture for 11 days. Pale green-brown solid, m.p. 133–135 °C, yield 0.040 g (44%). 1H NMR (CD3CN, 400.1 MHz): δ 9.74 (br.s, 1Н), 7.26 (d, 1Н, 3J = 8.7 Hz), 6.80–6.68 (m, 3Н), 2.77 (s, 3H). 13C{1H} NMR (CD3CN, 100.6 MHz): δ 145.9, 131.4, 128.5, 125.7 (q, 2JCF = 38.5 Hz), 122.8 (q, 1JCF = 266.3 Hz), 116.2, 113.5, 103.4 (q, 3JCF = 3.4 Hz), 101.0, 31.4. 19F NMR (CD3CN, 376.5 MHz): δ −59.3 (d, 3F, 4J = 0.9 Hz). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C10H10F3N2+: 215.0791; found: 215.0792.
N-Hexyl-2-(trifluoromethyl)-1H-indole-5-amine (10g). Obtained from styrene 2n (0.100 g, 0.370 mmol) and n-hexylamine (0.482 g) by heating at 100 °C for 4 h. Pale yellow-brown solid, m.p. 88–90 °C, yield 0.047 g (45%). 1H NMR (CDCl3, 400.1 MHz): δ 8.31 (br.s, 1Н), 7.17 (d, 1Н, 3J = 8.8 Hz), 6.82 (d, 1Н, 4J = 2.1 Hz), 6.77–6.69 (m, 2H), 3.16–3.10 (m, 2Н), 2.96 (br.s, 1H), 1.65 (dt, 2Н, 3J = 14.7 Hz, 3J = 7.2 Hz), 1.48–1.29 (m, 6H), 0.91 (t, 3H, 3J = 7.0 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 143.4, 130.3, 127.7, 125.6 (q, 2JCF = 38.6 Hz), 121.4 (q, 1JCF = 267.4 Hz), 115.4, 112.3, 103.3 (q, 3JCF = 3.3 Hz), 102.2, 45.1, 31.7, 29.5, 26.9, 22.6, 14.0. 19F NMR (CDCl3, 376.5 MHz): δ −61.5 (d, 3F, 4J = 1.0 Hz). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C15H20F3N2+: 285.1573; found: 285.1576.
Reactions of indole 4a with electrophiles.
Synthesis of 2-(trifluoromethyl)-1H-indol-3-carbaldehyde (17). A 4 mL vial with a screw cup was charged with DMF (0.5 mL), cooled to −18 °C (in the fridge) and then POCl3 (0.210 g, 1.37 mmol) was added. The reaction mixture was kept at 5–7 °C (in the fridge) for 30 min and then indole 4a (0.108 g, 0.58 mmol). The reaction mixture was stirred for 6h at 80 °C, cooled down to room temperature and transferred to separating funnel with water (50 mL) using CH2Cl2 (30–40 mL). After shaking, organic phase was separated, water phase was extracted with CH2Cl2 (20 mL). Combined organic phase was washed with water (20 mL), and dried over Na2SO4. Volatiles were evaporated in vacuo, the residue formed was suspended in hexane-CH2Cl2 mixture (3:1, 2 mL). The precipitate was filtered off and dried in vacuo to give pure 17. Beige powder, m.p. 167–169 °C, yield 0.066 g (53%). NMR data of indole 17 (see Supplementary Materials) are in agreement with those in the literature [66].
1-(2-(Trifluoromethyl)-1H-indol-3-yl)ethanone (18). An 8 mL vial with a screw cup was charged with 1,2-dichloroethane (1.5 mL), AlCl3 (0.124 g, 0.93 mmol), cooled to −18 °C (in the fridge) and then AcCl (0.047 g, 0.60 mmol) was added. The reaction mixture was stirred at room temperature for 30 min and then indole 4a (0.089 g, 0.48 mmol) was added. The reaction mixture was stirred overnight and poured into water (50 mL). Water phase was extracted with CH2Cl2 (3 × 20 mL). Combined organic phase was washed with water (20 mL), and dried over Na2SO4. Volatiles were evaporated in vacuo, the residue was purified by column chromatography on silica gel using CH2Cl2 followed by mixture of CH2Cl2 and MeOH (100:1) as eluents. Beige powder, m.p. 125–127 °C, yield 0.070 g (64%). 1H NMR (CD3CN, 400.1 MHz): δ 10.77 (br.s, 1Н), 8.11 (d, 1Н, 3J = 8.2 Hz), 7.60–7.56 (m, 1Н), 7.41–7.36 (m, 1Н), 7.35–7.30 (m, 1H), 2.66 (s, 3H). 13C{1H} NMR (DMSO-d6, 100.6 MHz): δ 192.7, 134.8, 126.9 (q, 2JCF = 38.1 Hz), 125.4, 125.3, 124.8 (d, 4JCF = 3.0 Hz), 123.0, 121.9, 121.1 (q, 1JCF = 269.6 Hz), 116.9 (q, 3JCF = 1.5 Hz), 113.4 (d, 3JCF = 6.2 Hz), 31.0. 19F NMR (CD3CN, 376.5 MHz): δ −58.0 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C11H9F3NO+: 228.0631; found: 228.0635.
(E)-1,1,1-Trifluoro-4-(2-(trifluoromethyl)-1H-indol-3-yl)but-3-en-2-one (20). An 8 mL vial with a screw cup was charged with indole 4a (0.091 g, 0.49 mmol), (E)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one 19 (0.090 g, 0.54 mmol), 1,2-dichloroethane (1 mL), and BF3·Et2O (0.083 g, 0.059 mmol). The reaction mixture was stirred for 2h at 80 °C and poured into water (30 mL). Water phase was extracted with CH2Cl2 (3 × 20 mL). Combined organic phase was washed with water (20 mL), and dried over Na2SO4. Volatiles were evaporated in vacuo, the residue was purified by column chromatography on silica gel using mixtures of hexane and CH2Cl2 (3:1 followed by 1:1) as eluents. Yellow powder, m.p. 125–127 °C, yield 0.0563 g (37%). 1H NMR (CDCl3, 400.1 MHz): δ 9.07 (br.s, 1Н), 8.30 (d, 1Н, 3J = 15.9 Hz), 7.98 (d, 1Н, 3J = 8.0 Hz), 7.53 (d, 1Н, 3J = 8.0 Hz), 7.50–7.43 (m, 1Н), 7.43–7.38 (m, 1H), 7.20 (d, 1Н, 3J = 15.9 Hz). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 180.1 (q, 2JCF = 35.1 Hz), 139.7, 135.3, 128.9 (q, 2JCF = 37.4 Hz), 126.2, 125.0, 123.7, 121.7, 120.7 (q, 1JCF = 270.5 Hz), 116.5 (q, 1JCF = 290.6 Hz), 116.6, 112.8, 112.7 (q, 3JCF = 2.3 Hz). 19F NMR (CDCl3, 376.5 MHz): δ −59.0 (d, 3F, 4J = 0.8 Hz), −78.7 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C13H8F6NO+: 308.0505; found: 308.0509.
Reactions of indole 4a with benzaldehydes in alcohols under catalysis with MeSO3H (general procedure VII). A 4 mL vial with a screw cup was charged with indole 4a (0.0925 g, 0.5 mmol), alcohol (MeOH or EtOH, 1 mL), corresponding benzaldehyde (0.6 mmol or 0.25 mmol for 23) and MeSO3H (0.050g, 0.53 mmol). The reaction mixture was heated at 80 °C for appropriate time, volatiles were evaporated in vacuo, the residue was purified by column chromatography on silica gel using mixtures of hexane and CH2Cl2 (3:1 followed by 1:1) as eluents.
3-(Methoxy(phenyl)methyl)-2-(trifluoromethyl)-1H-indole (21a). Obtained by the reaction of 4a (0.0925 g, 0.5 mmol) with benzaldehyde (0.065 g, 0.6 mmol) in MeOH by heating for 8h. White crystals, m.p. 86–88 °C, yield 0.100 g (68%). NMR data of indole 21a (see Supplementary Materials) are in agreement with those in the literature [84].
3-((4-Chlorophenyl)(methoxy)methyl)-2-(trifluoromethyl)-1H-indole (21b). Obtained by the reaction of 4a (0.0925 g, 0.5 mmol) with 4-chlorobenzaldehyde (0.084 g, 0.6 mmol) in MeOH by heating for 10h. White crystals, m.p. 112–113 °C, yield 0.112 g (66%). 1H NMR (CDCl3, 400.1 MHz): δ 8.44 (br.s, 1Н), 7.72 (d, 1Н, 3J = 8.1 Hz), 7.46–7.35 (m, 3Н), 7.35–7.25 (m, 3Н), 7.11 (ddd, 1Н, 3J = 8.1 Hz, 3J = 7.0 Hz, 4J = 1.0 Hz), 5.79 (s, 1H), 3.41 (s, 3Н). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 139.8, 135.4, 133.0, 128.3, 127.7, 125.2, 125.1, 123.2 (q, 2JCF = 37.1 Hz), 122.7, 121.7 (q, 1JCF = 269.3 Hz), 121.2, 117.3 (q, 3JCF = 2.4 Hz), 111.7, 56.9. 19F NMR (CDCl3, 376.5 MHz): δ −58.2 (s, 3F). HRMS (ESI-TOF): m/z [M-MeO]- Calcd for C16H10ClF3N+: 308.0448; found: 308.0450.
3-(Methoxy(4-methoxyphenyl)methyl)-2-(trifluoromethyl)-1H-indole (21c). Obtained by the reaction of 4a (0.098 g, 0.53 mmol) with 4-methoxybenzaldehyde (0.087 g, 0.636 mmol) in MeOH by heating for 12h. Pale brown powder, m.p. 138-140 °С, yield 0.092 g (52%). NMR data of indole 21c (see Supplementary Materials) are in agreement with those in the literature [84].
3-(Ethoxy(phenyl)methyl)-2-(trifluoromethyl)-1H-indole (22). Obtained by the reaction of 4a (0.048 g, 0.259 mmol) with benzaldehyde (0.033 g, 0.306 mmol) in EtOH by heating for 8h. White crystals, m.p. 129–132 °C, yield 0.061 g (74%). NMR data of indole 22 (see Supplementary Materials) are in agreement with those in the literature [84].
3,3’-(Phenylmethylene)bis(2-(trifluoromethyl)-1H-indole) (23). Obtained by the reaction of 4a (0.087 g, 0.47 mmol) with benzaldehyde (0.026 g, 0.241 mmol) in EtOH by heating for 12h. Brown oil, yield 0.0486 g (45%). 1H NMR (CDCl3, 400.1 MHz): δ 8.41 (br.s, 2Н), 7.39 (d, 2Н, 3J = 8.3 Hz), 7.27 (d, 2Н, 4J = 2.2 Hz), 7.25–7.16 (m, 5H), 6.84 (ddd, 2Н, 3J = 8.1 Hz, 3J = 7.0 Hz, 4J = 1.0 Hz), 6.72 (d, 2Н, 3J = 8.1 Hz), 6.54 (s, 1H). 13C{1H} NMR (CDCl3, 100.6 MHz): δ 142.0, 135.0, 128.8, 128.3, 127.2, 126.8, 124.3, 122.4 (q, 2JCF = 37.5 Hz), 122.3, 121.7 (q, 1JCF = 269.6 Hz), 120.8, 118.8 (q, 3JCF = 1.5 Hz), 111,7, 38,0. 19F NMR (CDCl3, 376.5 MHz): δ −60.0 (s, 3F). HRMS (ESI-TOF): m/z [M + H]+ Calcd for C25H17F6N2+: 459.1290; found: 459.1290.

4. Conclusions

In conclusion, we elaborated a novel three-step pathway towards 2-CF3-indoles starting from 2-nitrobenzaldehydes. Catalytic olefination reaction of 2-nitrobenzaldehydes with CF3CCl3 leads, efficiently, to the corresponding trifluoromethylated ortho-nitrostyrenes. The second step is a one pot formation of α-CF3-β-(2-nitroaryl) enamines by the reaction with pyrrolidine. Finally, reduction of nitro group by Fe-AcOH-H2O system initiated intramolecular cyclization to form 2-CF3-indoles in up to 85% yields. A broad synthetic scope and simplicity of the procedures of all steps are the distinct advantages of the method. The prepared trifluoromethylated indoles are valuable staring materials to synthesize 3-functionalized derivatives using some reactions with C-electrophiles.

Supplementary Materials

Copy of all 1H, 13C and 19F NMR spectra; Scheme S1: Olefination of 2-nitrobenzaldehydes by various methods; Scheme S2: Compositions of the reaction mixture in the synthesis of enamines 3; Scheme S3: Structure of enamines 1216 in the synthesis of indoles 10.

Author Contributions

Conceptualization, V.M.M. and V.G.N.; methodology, V.M.M.; validation, V.M.M.; formal analysis, V.M.M.; investigation, V.M.M. and Z.A.S.; writing—original draft preparation, V.M.M.; writing—review and editing, V.M.M., Z.A.S., V.T.A. and V.G.N.; visualization, V.M.M.; supervision, V.M.M.; project administration, V.G.N.; funding acquisition, V.G.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by RUSSIAN SCIENCE FOUNDATION, grant number 18-13-00136.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in Supplementary Materials.

Acknowledgments

The authors acknowledge partial support from M. V. Lomonosov Moscow State University Program of Development.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 3 and 4 are available from the authors.

References

  1. Baeyer, A. Ueber die reduction aromatischer verbindungen mittelst zinkstaub (On the reduction of aromatic compounds by means of zinc dust). Ann. Chem. Pharm. 1866, 140, 295–296. [Google Scholar] [CrossRef] [Green Version]
  2. Vitaku, E.; Smith, D.T.; Njardarson, J.T. Metal-free synthesis of fluorinated indoles enabled by oxidative dearomatization. Angew. Chem. 2016, 128, 2283–2287. [Google Scholar] [CrossRef]
  3. Pindur, U.; Adam, R. Synthetically attractive indolization processes and newer methods for the preparation of selectively substituted indole. J. Heterocycl. Chem. 1988, 25, 1–8. [Google Scholar] [CrossRef]
  4. Cacchi, S.; Fabrizi, G. Synthesis and functionalization of indoles through palladium-catalyzed reactions. Chem. Rev. 2005, 105, 2873–2920. [Google Scholar] [CrossRef]
  5. Humphrey, G.R.; Kuethe, J.T. Practical methodologies for the synthesis of indoles. Chem. Rev. 2006, 106, 2875–2911. [Google Scholar] [CrossRef]
  6. Taber, D.F.; Tirunahari, P.K. Indole synthesis: A review and proposed classification. Tetrahedron 2011, 67, 7195–7210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Cacchi, S.; Fabrizi, G. Update 1 of: Synthesis and functionalization of indoles through palladium-catalyzed reactions. Chem. Rev. 2011, 111, PR215–PR283. [Google Scholar] [CrossRef] [PubMed]
  8. Platon, M.; Amardeil, R.; Djakovitch, L.; Hierso, J.C. Progress in palladium-based catalytic systems for the sustainable synthesis of annulated heterocycles: A focus on indole backbones. Chem. Soc. Rev. 2012, 41, 3929–3968. [Google Scholar] [CrossRef] [PubMed]
  9. De Sa Alves, F.R.; Barreiro, E.J.; Fraga, C.A.M. From nature to drug discovery: The indole scaffold as a “privileged structure”. Mini-Rev. Med. Chem. 2009, 9, 782–793. [Google Scholar] [CrossRef]
  10. Vitaku, E.; Smith, D.T.; Njardarson, J.T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 2014, 57, 10257–10274. [Google Scholar] [CrossRef] [PubMed]
  11. McGrath, N.A.; Brichacek, M.; Njardarson, J.T. A graphical journey of innovative organic architectures that have improved our lives. J. Chem. Educ. 2010, 87, 1348–1349. [Google Scholar] [CrossRef]
  12. Liang, T.; Neumann, C.N.; Ritter, T. Introduction of fluorine and fluorine-containing functional groups. Angew. Chem. Int. Ed. 2013, 52, 8214–8264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Yang, X.; Wu, T.; Phipps, R.J.; Toste, F.D. Advances in catalytic enantioselective fluorination, mono-, di-, and trifluoromethylation, and trifluoromethylthiolation reactions. Chem. Rev. 2015, 115, 826–870. [Google Scholar] [CrossRef] [Green Version]
  14. Ahrens, T.; Kohlmann, J.; Ahrens, M.; Braun, T. Functionalization of fluorinated molecules by transition metal mediated C−F bond activation to access fluorinated building blocks. Chem. Rev. 2015, 115, 931–972. [Google Scholar] [CrossRef]
  15. Nenajdenko, V.G.; Muzalevskiy, V.M.; Shastin, A.V. Polyfluorinated ethanes as versatile fluorinated C2-building blocks for organic synthesis. Chem. Rev. 2015, 115, 973–1050. [Google Scholar] [CrossRef] [PubMed]
  16. Yerien, D.E.; Barata-Vallejo, S.; Postigo, A. Difluoromethylation reactions of organic compounds. Chem. Eur. J. 2017, 23, 14676–14701. [Google Scholar] [CrossRef] [PubMed]
  17. Jeschke, P. The unique role of fluorine in the design of active ingredients for modern crop protection. ChemBioChem 2004, 5, 570–589. [Google Scholar] [CrossRef] [PubMed]
  18. Jeschke, P. The unique role of halogen substituents in the design of modern agrochemicals. Pest Manage. Sci. 2010, 66, 10–27. [Google Scholar] [CrossRef]
  19. Fujiwara, T.; O’Hagan, D. Successful fluorine-containing herbicide agrochemicals. J. Fluor. Chem. 2014, 167, 16–29. [Google Scholar] [CrossRef]
  20. Jeschke, P. Latest generation of halogen-containing pesticides. Pest Manage. Sci. 2017, 73, 1053–1056. [Google Scholar] [CrossRef] [PubMed]
  21. Bégué, J.P.; Bonnet-Delpon, D. Bioorganic and Medicinal Chemistry of Fluorine; John Wiley & Sons: Hoboken, NJ, USA, 2008. [Google Scholar]
  22. Fluorine and Health. Molecular Imaging, Biomedical Materials and Pharmaceuticals; Tressaud, A., Haufe, G., Eds.; Elsevier: Amsterdam, The Netherlands, 2008; pp. 553–778. [Google Scholar]
  23. Kirsch, P. Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications; Wiley-VCH: Weinheim, Germany, 2013. [Google Scholar]
  24. Purser, S.; Moore, P.R.; Swallow, S.; Gouverneur, V. Fluorine in medicinal chemistry. Chem. Soc. Rev. 2008, 37, 320–330. [Google Scholar] [CrossRef] [PubMed]
  25. Hagmann, W.K. The many roles for fluorine in medicinal chemistry. J. Med. Chem. 2008, 51, 4359–4369. [Google Scholar] [CrossRef]
  26. Wang, J.; Sánchez-Roselló, M.; Aceña, J.L.; del Pozo, C.; Sorochinsky, A.E.; Fustero, S.; Soloshonok, V.A.; Liu, H. Fluorine in pharmaceutical industry: Fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem. Rev. 2014, 114, 2432–2506. [Google Scholar] [CrossRef]
  27. Ilardi, E.A.; Vitaku, E.; Njardarson, J.T. Data-mining for sulfur and fluorine: An evaluation of pharmaceuticals to reveal opportunities for drug design and discovery. J. Med. Chem. 2014, 57, 2832–2842. [Google Scholar] [CrossRef] [PubMed]
  28. Zhu, W.; Wang, J.; Wang, S.; Gu, Z.; Aceña, J.L.; Izawa, K.; Liu, H.; Soloshonok, V.A. Recent advances in the trifluoromethylation methodology and new CF3-containing drugs. J. Fluor. Chem. 2014, 167, 37–54. [Google Scholar] [CrossRef]
  29. Gillis, E.P.; Eastman, K.J.; Hill, M.D.; Donnelly, D.J.; Meanwell, N.A. Applications of fluorine in medicinal chemistry. J. Med. Chem. 2015, 58, 8315–8359. [Google Scholar] [CrossRef] [PubMed]
  30. Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J.L.; Soloshonok, V.A.; Izawa, K.; Liu, H. Next generation of fluorine containing pharmaceuticals, compounds currently in phase II−III clinical trials of major pharmaceutical companies: New structural trends and therapeutic areas. Chem. Rev. 2016, 116, 422–518. [Google Scholar] [CrossRef]
  31. Meanwell, N.A. Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design. J. Med. Chem. 2018, 61, 5822–5880. [Google Scholar] [CrossRef]
  32. Inoue, M.; Sumii, Y.; Shibata, N. Contribution of organofluorine compounds to pharmaceuticals. ACS Omega 2020, 5, 10633–10640. [Google Scholar] [CrossRef] [PubMed]
  33. De la Torre, B.G.; Albericio, F. The pharmaceutical industry in 2020. An analysis of FDA drug approvals from the perspective of molecules. Molecules 2021, 26, 627. [Google Scholar] [CrossRef]
  34. Fluorine in Heterocyclic Chemistry; Nenajdenko, V.G. (Ed.) Springer: Heidelberg, Germany, 2014; Volume 1, p. 681. [Google Scholar]
  35. Fluorine in Heterocyclic Chemistry; Nenajdenko, V.G. (Ed.) Springer: Heidelberg, Germany, 2014; Volume 2, p. 760. [Google Scholar]
  36. Fluorinated Heterocyclic Compounds: Synthesis, Chemistry, and Applications; Petrov, V.A. (Ed.) Wiley: Hoboken, NJ, USA, 2009. [Google Scholar]
  37. Fluorinated Heterocycles; Gakh, A.; Kirk, K.L. (Eds.) Oxford University Press: Oxford, UK, 2008. [Google Scholar]
  38. Muzalevskiy, V.M.; Nenajdenko, V.G.; Shastin, A.V.; Balenkova, E.S.; Haufe, G. Synthesis of trifluoromethyl pyrroles and their benzo analogues. Synthesis 2009, 2009, 3905–3929. [Google Scholar]
  39. Serdyuk, O.V.; Abaev, V.T.; Butin, A.V.; Nenajdenko, V.G. Synthesis of fluorinated thiophenes and their analogues. Synthesis 2011, 2011, 2505–2529. [Google Scholar] [CrossRef]
  40. Serdyuk, O.V.; Muzalevskiy, V.M.; Nenajdenko, V.G. Synthesis and properties of fluoropyrroles and their analogues. Synthesis 2012, 2012, 2115–2137. [Google Scholar]
  41. Politanskaya, L.V.; Selivanova, G.A.; Panteleeva, E.V.; Tretyakov, E.V.; Platonov, V.E.; Nikul’shin, P.V.; Vinogradov, A.S.; Zonov, Y.A.V.; Karpov, V.M.; Mezhenkova, T.V.; et al. Organofluorine chemistry: Promising growth areas and challenges. Russ. Chem. Rev. 2019, 88, 425–569. [Google Scholar] [CrossRef]
  42. Available online: https://www.reaxys.com/#/search/quick (accessed on 4 November 2021).
  43. Blobaum, A.L.; Uddin, J.; Felts, A.S.; Crews, B.C.; Rouzer, C.A.; Marnett, L.J. The 2′-trifluoromethyl analogue of indomethacin is a potent and selective COX-2 inhibitor. ACS Med. Chem. Lett. 2013, 4, 486–490. [Google Scholar] [CrossRef] [PubMed]
  44. Ganesh, T.; Jiang, J.; Yang, M.-S.; Dingledine, R. Optimization studies of cinnamic amide EP2 antagonists. J. Med. Chem. 2014, 57, 4173–4184. [Google Scholar] [CrossRef] [PubMed]
  45. Trabbic, C.J.; Overmeyer, J.H.; Alexander, E.M.; Crissman, E.J.; Kvale, H.M.; Smith, M.A.; Erhardt, P.W.; Maltese, W.A. Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity. J. Med. Chem. 2015, 5, 2489–2512. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Trabbic, C.J.; George, S.M.; Alexander, E.M.; Du, S.; Offenbacher, J.M.; Crissman, E.J.; Overmeyer, J.H.; Maltese, W.A.; Erhardt, P.W. Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity. Eur. J. Med. Chem. 2016, 122, 79–91. [Google Scholar] [CrossRef] [Green Version]
  47. Rheinheimer, J.; Rath, R.; Kulkarni, S.; Rosenbaum, C.; Wiebe, C.; Brahm, L.; Siepe, I.; Haden, E.; Roehl, F.; Khanna, S.; et al. Indole and Azaindole Compounds with Substitued 6-Membered Aryl and Heteroaryl Rings as Agrochemical Fungicides. Patent WO201957660, 28 March 2019. [Google Scholar]
  48. Yoshida, M.; Yoshida, T.; Kobayashi, M.; Kamigata, N. Perfluoroalkylations of nitrogen-containing heteroaromatic compounds with bis(perfluoroalkanoyl) peroxides. J. Chem. Soc. Perkin Trans. I 1989, 909–914. [Google Scholar] [CrossRef]
  49. Chen, Q.-Y.; Li, Z.-T. Photoinduced electron-transfer reaction of difluorodiiodomethane with azaaromatic compounds and enamines. J. Chem. Soc. Perkin Trans. I 1993, 645–648. [Google Scholar] [CrossRef]
  50. Shimizu, R.; Egami, H.; Nagi, T.; Chae, J.; Hamashima, Y.; Sodeoka, M. Direct C2-trifluoromethylation of indole derivatives catalyzed by copper acetate. Tetrahedron Lett. 2010, 51, 5947–5949. [Google Scholar] [CrossRef]
  51. Wiehn, M.S.; Vinogradova, E.V.; Togni, A. Electrophilic trifluoromethylation of arenes and N-heteroarenes using hypervalent iodine reagents. J. Fluor. Chem. 2010, 131, 951–957. [Google Scholar] [CrossRef]
  52. Rey-Rodriguez, R.; Retailleau, P.; Bonnet, P.; Gillaizeau, I. Iron-catalyzed trifluoromethylation of enamide. Chem. Eur. J. 2015, 21, 3572–3575. [Google Scholar] [CrossRef] [PubMed]
  53. Jacquet, J.; Blanchard, S.; Derat, E.; Desage-El Murr, M.; Fensterbank, L. Redox-ligand sustains controlled generation of CF3 radicals by well-defined copper complex. J. Chem. Sci. 2016, 7, 2030–2036. [Google Scholar] [CrossRef] [Green Version]
  54. Kino, T.; Nagase, Y.; Ohtsuka, Y.; Yamamoto, K.; Uraguchi, D.; Tokuhisa, K.; Yamakawa, T. Trifluoromethylation of various aromatic compounds by CF3I in the presence of Fe(II) compound, H2O2 and dimethylsulfoxide. J. Fluor. Chem. 2010, 131, 98–105. [Google Scholar] [CrossRef]
  55. Straathof, N.J.W.; Gemoets, H.P.L.; Wang, X.; Schouten, J.C.; Hessel, V.; Noel, T. Rapid trifluoromethylation and perfluoroalkylation of five-membered heterocycles by photoredox catalysis in continuous flow. ChemSusChem 2014, 7, 1612–1617. [Google Scholar] [CrossRef] [PubMed]
  56. Choi, W.J.; Choi, S.; Ohkubo, K.; Fukuzumi, S.; Cho, E.J.; You, Y. Mechanisms and applications of cyclometalated Pt(II) complexes in photoredox catalytic trifluoromethylation. J. Chem. Sci. 2015, 6, 1454–1464. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Du, Y.; Pearson, R.M.; Lim, C.-H.; Sartor, S.M.; Ryan, M.D.; Yang, H.A.; Damrauer, N.H.; Miyake, G.M. Strongly reducing, visible-light organic photoredox catalysts as sustainable alternatives to precious metals. Chem. Eur. J. 2017, 23, 10962–10968. [Google Scholar] [CrossRef]
  58. Monteiro, J.L.; Carneiro, P.F.; Elsner, P.; Roberge, D.M.; Wuts, P.G.M.; Kurjan, K.C.; Gutmann, B.; Kappe, C.O. Continuous flow homolytic aromatic substitution with electrophilic radicals: A fast and scalable protocol for trifluoromethylation. Chem. Eur. J. 2017, 23, 176–186. [Google Scholar] [CrossRef] [PubMed]
  59. Cheng, Y.; Yuan, X.; Ma, J.; Yu, S. Direct aromatic C-H trifluoromethylation via an electron-donor-acceptor complex. Chem. Eur. J. 2015, 21, 8355–8359. [Google Scholar] [CrossRef]
  60. Meucci, E.A.; Nguyen, S.N.; Camasso, N.M.; Chong, E.; Ariafard, A.; Canty, A.J.; Sanford, M.S. Nickel(IV)-catalyzed C-H trifluoromethylation of (hetero)arenes. J. Am. Chem. Soc. 2019, 141, 12872–12879. [Google Scholar] [CrossRef] [PubMed]
  61. Morstein, J.; Hou, H.; Cheng, C.; Hartwig, J.F. Trifluoromethylation of arylsilanes with [(phen)CuCF3]. Angew. Chem. Int. Ed. 2016, 55, 8054–8057. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Abdiaj, I.; Bottecchia, C.; Alcazar, J.; Noël, T. Visible-light-induced trifluoromethylation of highly functionalized arenes and heteroarenes in continuous flow. Synthesis 2017, 49, 4978–4985. [Google Scholar]
  63. Miller, S.A.; van Beek, B.; Hamlin, T.A.; Bickelhaupt, F.M.; Leadbeater, N.E. A methodology for the photocatalyzed radical trifluoromethylation of indoles: A combined experimental and computational study. J. Fluor. Chem. 2018, 214, 94–100. [Google Scholar] [CrossRef]
  64. Xie, J.-J.; Wang, Z.-Q.; Jiang, G.-F. Metal-free oxidative trifluoromethylation of indoles with CF3SO2Na on the C2 position. RSC Adv. 2019, 9, 35098–35101. [Google Scholar] [CrossRef] [Green Version]
  65. Bazyar, Z.; Hosseini-Sarvari, M. Au@ZnO core-shell: Scalable photocatalytic trifluoromethylation using CF3CO2Na as an inexpensive reagent under visible light irradiation. Org. Process Res. Dev. 2019, 23, 2345–2353. [Google Scholar] [CrossRef]
  66. Ye, Y.; Cheung, K.P.S.; He, L.; Tsui, G.C. Synthesis of 2-(trifluoromethyl)indoles via domino trifluoromethylation/cyclization of 2-alkynylanilines. Org. Lett. 2018, 20, 1676–1679. [Google Scholar] [CrossRef]
  67. Pedroni, J.; Cramer, N. 2-(Trifluoromethyl)indoles via Pd(0)-catalyzed C(sp3)-H functionalization of trifluoroacetimidoyl chlorides. Org. Lett. 2016, 18, 1932–1935. [Google Scholar] [CrossRef]
  68. Doebelin, C.; Patouret, R.; Garcia-Ordonez, R.D.; Chang, M.R.; Dharmarajan, V.; Kuruvilla, D.S.; Novick, S.J.; Lin, I.; Cameron, M.D.; Griffin, P.R.; et al. N-Arylsulfonyl indolines as retinoic acid receptor-related orphan receptor γ (RORγ) agonists. ChemMedChem 2016, 11, 2607–2620. [Google Scholar] [CrossRef] [Green Version]
  69. Wang, Z.; Ma, Q. A New and efficient one-pot synthesis of 2-fluoroalkyl substituted indoles. J. Heterocycl. Chem. 2015, 52, 1893–1896. [Google Scholar] [CrossRef]
  70. Wang, Z.-X.; Zhang, T.-F.; Ma, Q.-W.; Ni, W.-G. Bromotriphenylphosphonium salt promoted one-pot cyclization to 2-fluoroalkyl-substituted indoles. Synthesis 2014, 46, 3309–3314. [Google Scholar] [CrossRef]
  71. Ge, F.; Wang, Z.; Wan, W.; Hao, J. Grignard cyclization reaction of fluorinated N-arylimidoyl chlorides: A novel and facile access to 2-fluoroalkyl indoles. Synlett 2007, 2007, 447–450. [Google Scholar] [CrossRef]
  72. Wang, Z.; Ge, F.; Wan, W.; Jiang, H.; Hao, J. Fluorinated N-[2-(haloalkyl)phenyl]imidoyl chloride, a key intermediate for the synthesis of 2-fluoroalkyl substituted indole derivatives via Grignard cyclization process. J. Fluor. Chem. 2007, 128, 1143–1152. [Google Scholar] [CrossRef]
  73. Miyashita, K.I.; Tsuchiya, K.; Kondoh, K.; Miyabe, H.; Imanishi, T. Novel indole-ring construction method for the synthesis of 2-trifluoromethylindoles. Heterocycles 1996, 42, 513–516. [Google Scholar]
  74. Miyashita, K.; Kondoh, K.; Tsuchiya, K.; Miyabe, H.; Imanishi, T. Novel indole-ring formation by thermolysis of 2-(N-acylamino)benzylphosphonium salts. Effective synthesis of 2-trifluoromethylindoles. J. Chem. Soc. Perkin Trans. I 1996, 1261–1268. [Google Scholar] [CrossRef]
  75. Henegar, K.E.; Hunt, D.A. Expedient preparations of 2-trifluoromethylindole and its n-methyl derivative. Heterocycles 1996, 43, 1471–1475. [Google Scholar]
  76. Walewska-Królikiewicz, M.; Wilk, B.; Kwast, A.; Wróbel, Z. Two-step, regioselective, multigram-scale synthesis of 2-(trifluoromethyl)indoles from 2-nitrotoluenes. Tetrahedron Lett. 2021, 86, 153515. [Google Scholar] [CrossRef]
  77. Bujok, R.; Wrbel, Z.; Wojciechowski, K. Expedient synthesis of 1-hydroxy-4- and 1-hydroxy-6-nitroindoles. Synlett 2012, 23, 1315–1320. [Google Scholar]
  78. Muzalevskiy, V.M.; Nenajdenko, V.G.; Rulev, A.Y.U.; Ushakov, I.A.; Romanenko, G.V.; Shastin, A.V.; Balenkova, E.S.; Haufe, G. Selective synthesis of α-trifluoromethyl-β-arylenamines or vinylogous guanidinium salts by treatment of β-halo-β-trifluoromethylstyrenes with secondary amines under different conditions. Tetrahedron 2009, 65, 6991–7000. [Google Scholar] [CrossRef]
  79. Goldberg, A.A.; Muzalevskiy, V.M.; Shastin, A.V.; Balenkova, E.S.; Nenajdenko, V.G. Novel efficient synthesis of β-fluoro-β-(trifluoromethyl)styrenes. J. Fluor. Chem. 2010, 131, 384–388. [Google Scholar] [CrossRef]
  80. Rulev, A.Y.; Muzalevskiy, V.M.; Kondrashov, E.V.; Ushakov, I.A.; Shastin, A.V.; Balenkova, E.S.; Haufe, G.; Nenajdenko, V.G. A cascade approach to captodative trifluoromethylated enamines or vinylogous guanidinium salts: Aromatic substituents as switches of reaction direction. Eur. J. Org. Chem. 2010, 2010, 300–310. [Google Scholar]
  81. Muzalevskiy, V.M.; Nenajdenko, V.G.; Shastin, A.V.; Balenkova, E.S.; Haufe, G. α-Trifluoromethyl-β-aryl enamines in the synthesis of trifluoromethylated heterocycles by the Fischer and the Pictet–Spengler reactions. Tetrahedron 2009, 65, 7553–7561. [Google Scholar] [CrossRef]
  82. Muzalevskiy, V.M.; Sizova, Z.A.; Panyushkin, V.V.; Chertkov, V.A.; Khrustalev, V.N.; Nenajdenko, V.G. α,β-Disubstituted CF3-enones as a trifluoromethyl building block: Regioselective preparation of totally substituted 3-CF3-pyrazoles. J. Org. Chem. 2021, 86, 2385–2405. [Google Scholar] [CrossRef] [PubMed]
  83. Muzalevskiy, V.M.; Sizova, Z.A.; Abaev, V.T.; Nenajdenko, V.G. Synthesis of 2-trifluoromethylated quinolines from CF3-alkenes. Org. Biomol. Chem. 2021, 19, 4303–4319. [Google Scholar] [CrossRef] [PubMed]
  84. Muzalevskiy, V.M.; Sizova, Z.A.; Nenajdenko, V.G. Modular construction of functionalized 2-CF3-indoles. Org. Lett. 2021, 23, 5973–5977. [Google Scholar] [CrossRef]
  85. Muzalevskiy, V.M.; Shastin, A.V.; Balenkova, E.S.; Haufe, G.; Nenajdenko, V.G. Synthesis of alpha-trifluoromethyl-phenethylamines from alpha-trifluoromethyl beta-aryl enamines and beta-chloro-beta-(trifluoromethyl)styrenes. J. Fluor. Chem. 2011, 132, 1247–1253. [Google Scholar] [CrossRef]
  86. Korotchenko, V.N.; Shastin, A.V.; Nenajdenko, V.G.; Balenkova, E.S. Novel efficient synthesis of dibromoalkenes. A first example of catalytic olefination of aliphatic carbonyl compounds. Org. Biomol. Chem. 2003, 1, 1906–1908. [Google Scholar] [CrossRef]
  87. Nenajdenko, V.G.; Varseev, G.N.; Korotchenko, V.N.; Shastin, A.V.; Balenkova, E.S. Reaction of CBrF2-CBrF2 with hydrazones of aromatic aldehydes. Novel efficient synthesis of fluorocontaining alkanes, alkenes and alkynes. J. Fluor. Chem. 2004, 125, 1339–1345. [Google Scholar] [CrossRef]
  88. Nenajdenko, V.G.; Shastin, A.V.; Korotchenko, V.N.; Varseev, G.N.; Balenkova, E.S. A novel approach to 2-chloro-2-fluorostyrenes. Eur. J. Org. Chem. 2003, 2003, 302–308. [Google Scholar] [CrossRef]
  89. Hirotaki, K.; Kawazoe, G.; Hanamoto, T. Facile synthesis of (E)-β-(trifluoromethyl)styrenes from halothane (HCFC-123B1). J. Fluor. Chem. 2015, 171, 169–173. [Google Scholar] [CrossRef]
  90. Korotchenko, V.N.; Shastin, A.V.; Nenajdenko, V.G.; Balenkova, E.S. A novel approach to fluoro-containing alkenes. Tetrahedron 2001, 57, 7519–7527. [Google Scholar] [CrossRef]
  91. Gribble, G.W. Leimgruber–Batcho indole synthesis. In Indole Ring Synthesis; Gribble, G.W., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 2016. [Google Scholar]
  92. Muzalevskiy, V.M.; Shastin, A.V.; Balenkova, E.S.; Haufe, G.; Nenajdenko, V.G. New approaches to the synthesis of 2-(trifluoromethyl)indole and 2-amino-3-(trifluoromethyl)quinoline. Russ. Chem. Bull. 2008, 57, 2217–2219. [Google Scholar] [CrossRef]
  93. Egorova, K.S.; Ananikov, V.P. Toxicity of metal compounds: Knowledge and myths. Organometallics 2017, 36, 4071–4090. [Google Scholar] [CrossRef] [Green Version]
  94. Marien, N.; Reddy, B.N.; De Vleeschouwer, F.; Goderis, S.; Van Hecke, K.; Verniest, G. Metal-Free Cyclization of orto-nitroaryl ynamides and ynamines towards spiropseudoindoxyls. Angew. Chem. Int. Ed. 2018, 57, 5660–5664, [Angew. Chem. 2018, 130, 5762–5766]. [Google Scholar] [CrossRef] [PubMed]
  95. Patel, P.; Ramana, C.V. Divergent Pd(II) and Au(III) mediated nitroalkynol cycloisomerizations. Org. Biomol. Chem. 2011, 9, 7327–7334. [Google Scholar] [CrossRef]
  96. Shiri, M.; Zolfigol, M.A.; Kruger, H.G.; Tanbakouchian, Z. Bis- and trisindolylmethanes (BIMs and TIMs). Chem. Rev. 2010, 110, 2250–2293. [Google Scholar] [CrossRef] [PubMed]
  97. Beltrá, J.; Gimeno, M.C.; Herrera, R.P. A new approach for the synthesis of bisindoles through AgOTf as catalyst. Beilstein J. Org. Chem. 2014, 10, 2206–2214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Kotha, S.; Cheekatla, S.R.; Chinnam, A.K.; Jain, T. Design and synthesis of polycyclic bisindoles via Fischer indolization and ring-closing metathesis as key steps. Tetrahedron Lett. 2016, 57, 5605–5607. [Google Scholar] [CrossRef]
  99. Chantana, C.; Sirion, U.; Iawsipo, P.; Jaratjaroonphong, J. Short total synthesis of (±)-gelliusine E and 2,3′-bis(indolyl)ethylamines via PTSA-catalyzed transindolylation. J. Org. Chem. 2021, 86, 13360–13370. [Google Scholar] [CrossRef]
  100. Maciejewska, D.; Niemyjska, M.; Wolska, I.; Włostowski, M.; Rasztawicka, M. Synthesis, spectroscopic studies and crystal structure of 5,5′-dimethoxy-3,3′-methanediyl-bis-indole as the inhibitor of cell proliferation of human tumors. Z. Naturforsch. B 2004, 59, 1137–1142. [Google Scholar] [CrossRef]
  101. Lee, C.-H.; Yao, C.-F.; Huang, S.-M.; Ko, S.; Tan, Y.-H.; Lee-Chen, G.-J.; Wang, Y.-C. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models. Cancer 2008, 113, 815–825. [Google Scholar] [CrossRef] [PubMed]
  102. Safe, S.; Papineni, S.; Chintharlapalli, S. Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs. Cancer Lett. 2008, 269, 326–338. [Google Scholar] [CrossRef] [Green Version]
  103. Bell, M.C.; Crowley-Nowick, P.; Bradlow, H.L.; Sepkovic, D.W.; Schmidt-Grimminger, D.; Howell, P.; Mayeaux, E.J.; Tucker, A.; Turbat-Herrera, E.A.; Mathis, J.M. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol. 2000, 78, 123–129. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Hong, C.; Firestone, G.L.; Bjeldanes, L.F. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem. Pharmacol. 2002, 63, 1085–1097. [Google Scholar] [CrossRef]
  105. Le, H.T.; Schaldach, C.M.; Firestone, G.L.; Bjeldanes, L.F. Plant-derived 3,3′-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J. Biol. Chem. 2003, 278, 21136–21145. [Google Scholar] [CrossRef] [Green Version]
  106. Pindur, U.; Lemster, T. Advances in marine natural products of the indole and annelated indole. Curr. Med. Chem. 2001, 8, 1681–1698. [Google Scholar] [CrossRef]
  107. Kochanowska-Karamyan, A.J.; Hamann, M.T. Marine indole alkaloids: Potential new drug leads for the control of depression and anxiety. Chem. Rev. 2010, 110, 4489–4497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Veluri, R.; Oka, I.; Wagner-Döbler, I.; Laatsch, H. New indole alkaloids from the North Sea bacterium Vibrio parahaemolyticus Bio2491. J. Nat. Prod. 2003, 66, 1520–1523. [Google Scholar] [CrossRef] [PubMed]
  109. Chen, M.-W.; Zhang, X.-G.; Zhong, P.; Hu, M.-L. Efficient one-pot synthesis of 2-chloro-1,1,1-trifluoro-2-alkenes under solvent-free conditions. Synth. Commun. 2009, 39, 756–763. [Google Scholar] [CrossRef]
  110. Muzalevskiy, V.M.; Shastin, A.V.; Balenkova, E.S.; Nenajdenko, V.G. New approach to the synthesis of trifluoromethylvinyl sulfides. Russ. Chem. Bull. 2007, 56, 1526–1533. [Google Scholar] [CrossRef]
Figure 1. Representative 2-CF3-indoles having biological activity.
Figure 1. Representative 2-CF3-indoles having biological activity.
Molecules 26 07365 g001
Figure 2. Approaches to 2-CF3-indoles having free nitrogen atom and 3-position.
Figure 2. Approaches to 2-CF3-indoles having free nitrogen atom and 3-position.
Molecules 26 07365 g002
Scheme 1. Synthesis of ortho-nitrostyrenes 2.
Scheme 1. Synthesis of ortho-nitrostyrenes 2.
Molecules 26 07365 sch001
Scheme 2. Synthesis of indoles 4 from ortho-nitrostyrenes 2.
Scheme 2. Synthesis of indoles 4 from ortho-nitrostyrenes 2.
Molecules 26 07365 sch002
Scheme 3. Possible mechanism of formation of side product 5c in the reaction of 2c with pyrrolidine.
Scheme 3. Possible mechanism of formation of side product 5c in the reaction of 2c with pyrrolidine.
Molecules 26 07365 sch003
Scheme 4. Synthesis of enamine 3n and 2-CF3-indole 10a.
Scheme 4. Synthesis of enamine 3n and 2-CF3-indole 10a.
Molecules 26 07365 sch004
Scheme 5. Synthesis of indoles 10b and 4n.
Scheme 5. Synthesis of indoles 10b and 4n.
Molecules 26 07365 sch005
Scheme 6. Synthesis of amino substituted indoles 10c–g.
Scheme 6. Synthesis of amino substituted indoles 10c–g.
Molecules 26 07365 sch006
Scheme 7. Reactions of indole 4a with electrophiles.
Scheme 7. Reactions of indole 4a with electrophiles.
Molecules 26 07365 sch007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Muzalevskiy, V.M.; Sizova, Z.A.; Abaev, V.T.; Nenajdenko, V.G. An Efficient Approach to 2-CF3-Indoles Based on ortho-Nitrobenzaldehydes. Molecules 2021, 26, 7365. https://doi.org/10.3390/molecules26237365

AMA Style

Muzalevskiy VM, Sizova ZA, Abaev VT, Nenajdenko VG. An Efficient Approach to 2-CF3-Indoles Based on ortho-Nitrobenzaldehydes. Molecules. 2021; 26(23):7365. https://doi.org/10.3390/molecules26237365

Chicago/Turabian Style

Muzalevskiy, Vasiliy M., Zoia A. Sizova, Vladimir T. Abaev, and Valentine G. Nenajdenko. 2021. "An Efficient Approach to 2-CF3-Indoles Based on ortho-Nitrobenzaldehydes" Molecules 26, no. 23: 7365. https://doi.org/10.3390/molecules26237365

APA Style

Muzalevskiy, V. M., Sizova, Z. A., Abaev, V. T., & Nenajdenko, V. G. (2021). An Efficient Approach to 2-CF3-Indoles Based on ortho-Nitrobenzaldehydes. Molecules, 26(23), 7365. https://doi.org/10.3390/molecules26237365

Article Metrics

Back to TopTop